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1.1. Fluorine substituted amino acids and polypeptides 
 
 Fluorine containing substances are widely used in modern chemical industry 
and research. About 20-25% of all drugs in the pharmaceutical market contain at 
least one fluorine atom1. In agrochemicals this number is even higher ~ 30%2. This 
reasonably high abundance of synthetic organofluorine compounds reflects3 the 
unique properties of fluorine and its chemical bonds. The fluorine atom possesses a 
small van der Waals radius (1.47 Å) similar to hydrogen (1.20 Å), meaning that it 
is a good substitutient for hydrogen from the steric perspective. Polarity of the C-F 
bond is inversed in comparison to C-H, even though the molecular size remains 
very similar. The C-F bond is very stable against chemical modifications. The 
toxicity of organofluorine substances is significantly lower than of other 
organohalogenides. 
 Incorporation of fluorine into proteins for analytical purposes has also 
attracted significant attention4,5. Fluorine labeling enables sensitive 19F-NMR 
studies6, for instance membrane protein structure investigation7 or even in vivo 
protein detection8. 
Biosynthetic fluorine labeling can be done in two ways. The nucleophylicity 
of the side chains of cysteine, tyrosine and lysine, as well as disulfide bond 
formation in cysteine, enable chemical ligation of those residues with fluorine 
containing moieties9. Another opportunity is the selective biosynthetic 
incorporation by recombinant protein expression. Numerous fluorinated amino 
acids, derivatives of natural amino acids, were reported in proteins to date, of 
which aromatic ones are the most popular5.  
Chemical incorporation via peptide synthesis is more straightforward and 
should be preferred for shorter sequences (up to 30-40 residues). Synthetic fluorine 
labeling requires the amino acids to be available. Recent developments of the 
fluorine substituted amino acids synthesis have been reviewed10,11,12,13. 
Trifluormethylation of the peptide backbone has been discussed separately14.  
Other fluorinated so-called fluorous materials have been applied for 
numerous structural biological studies15,16, in particular they were used for 19F 
magnetic resonance imaging in tissues17. The application of fluorine in various 
aspects of medicinal and pharmaceutical chemistry has also been recently reviewed 
in a dedicated book18.  
 
1.2. Studies of membrane active peptides by solid state NMR 
 
1.2.1. Membrane active peptides 
 
 Membrane active peptides (MAPs) are a class of peptides with a broad 
functional range, all of which involve the interaction with cell membranes as an 
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obligatory step. The most well studied MAPs are antimicrobial and cell penetrating 
peptides. 
 Antibacterial peptides are known since 1939 when gramicidins were first 
extracted from the soil bacterium Bacillus brevis19. Since then, peptides with 
bactericidal action were found in all kinds of living organisms. Small (6-59 
residues) amphipathic, charged peptides (as well as protein fragments) are 
considered to be part of the innate immune system20. For some of them the 
mechanism of action was elucidated. Ion-channel formation was claimed for 
gramicidin A21, oligomeric “barrel stave” pores with 3-11 parallel helices were 
described for alamethicin, toroidal “wormhole” pores involving lipid molecules 
were postulated for magainin 222 (see Fig.1.1.). The disturbance of the membrane 
integrity via formation of long lived pores is the apparent reason of losing the 
membrane potential which is essential for ATP synthesis in prokaryotic cells. This 
is considered to be the prime mode of action for most cytotoxic MAPs. For many 
of antimicrobial peptides, for which the specific mechanism is not known, a 
“carpet” model was proposed23: the amphipathic peptides possess a high affinity to 
lipid membranes; after binding, the peptides significantly change the biophysical 
properties of the target membrane and make it unstable or leaky. However, many 
antimicrobial peptides showed also significant damage of eukaryotic cells such as 
human erythrocytes. The cell selectivity (prokaryotic vs eukaryotic) is very 









     


















Cell penetrating peptides were discovered about 20 years ago. They can 
cross lipid membranes and deliver different cargos (either bound covalently or as 
molecular complexes) into the cell26,27,28. The mechanisms of cell entry are believed 
to be either various endocytosis associated events or direct translocation. The latter 
may involve cooperative transient membrane bound structures, similar way as in 
antimicrobial peptides. Cell penetrating peptides are also short, positively charged 
and amphipathic. This suggests that both classes of MAPs are fundamentally 
similar and they could share same mechanism of action. 
 
1.2.2. Solid state 
19
F-NMR for investigation of peptide-membrane interaction 
 
Understanding the mechanisms of peptide-membrane interactions is an 
important biophysical task. It should reveal the reasons for cell selectivity as well 
as the structure activity relationships. The mechanism should also answer the 
question: how to tune a given peptide sequence to possess only the desired 
functionality (e.g. antimicrobial or cell penetrating)? From this perspective, solid 
state NMR can provide a significant insight. 
 Solid state 19F-NMR of peptides was successfully used for structural studies 
of MAPs. The method is based on specific labeling of peptide sequences with 
fluorine substituted amino acids, and investigation of the resulting peptides in 
model bilayers or even in native biomembranes29,30 . 
The different basic mechanisms (Fig. 1.1) can be distinquished from three 
simple characteristics: 1) alignment of the peptide relative to the membrane 
normal, 2) the oligomerization state of the peptide molecules, 3) mobility of the 
peptides. In solid state NMR experiments these parameters can be directly 
measured in macroscopically oriented samples of lipid bilayers (Fig.1.2.). If the 
peptide is carrying a label which is rigidly attached to the backbone, the orientation 
of the NMR label can be determined from the spectra in a suitable NMR 
experiments. The data must be collected from several independent locations in the 
peptide secondary structure. From several orientional constants the peptide 
orientation can be deduced. Distances between labels can also be measured by 
NMR. The mobility of peptide is reflected in the NMR spectra either after 
corresponding data analysis (e.g. getting Smol parameter) or by observation of the 
relaxation rate (T1, T2, T1ρ constants as well as the line widths). 
 Among the different NMR labels that could be applied for peptides, 2H, 13C, 
15N and 19F nuclei are normally used. Even though the fluorine atom is not present 
in natural peptides, 19F labeling has several significant advantages: the high NMR 
sensitivity of the 19F nucleus (0.94 of the 1H magnetogyric ratio), 100% natural 
abundance of the 19F isotope, and no natural background. Thus, the solid state 
NMR measurements can be performed fast and with a very low concentration of 
label in the sample. High sensitivity of 19F-NMR leads to significant shortening of 
the total spectral acquisition time compared to other labels. Qualitative changes in 
the peptide state cause qualitative changes in the resulting NMR spectra, which can 
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be easily observed. Because of the latter two reasons, 19F-NMR enables fast, high 
quality biophysical investigations under various conditions.  
 
Figure 1.2. Solid state NMR parameters used for characterizing MAPs in oriented membrane 
samples. The spectrometer magnetic field direction is shown as B0. The membrane normal is 
shown as N. The angle between the label and the bilayer normal (θ) and the inter-label distance 
(r) can be determined by the NMR experiments29. 
 
 Furthermore, the spectral parameters can be converted into quantitative 
values for characterizing the peptide mobility and orientation. The resonance 
frequency of the label with a spin of ½ is defined by the total Hamiltonian (Ĥres) 
with several contributious (eq. 1): isotropic chemical shielding (Ĥδ), indirect 
dipolar  coupling (ĤJ), chemical shift anisotropy (ĤCSA) and direct dipolar coupling 
(ĤD). The first two are present in solution NMR, and the last two ones additionally 
appear in solid state NMR and dominate the spectra in the case when anisotropy is 
present in the sample. 
Ĥres = Ĥδ + ĤJ + ĤCSA + ĤD (equation 1) 
 
 If the membrane bound peptide is labeled with a fluorine atom, the chemical 
shift depends on the label orientation (chemical shift anisotropy). The chemical 
shift in this case is composed of the isotropic and anisotropic contributions, where 
the latter is governed by the label tensor (spatial orientation). For instance, in the 
case of a trifluoromethyl group the chemical shift depends on the macroscopical 
orientation in the magnetic field of the spectrometer. In this case the additional 
interaction, dipolar coupling, will lead to an appearance of three spectral 
components (triplet), where the coupling constant depends also on the orientation, 












































∆ is the maximum dipolar splitting of the trifluoromethyl group (15.8 
kHz), and Smol is the molecular wobbling parameter (1 ≥ |Smol| ≥ 0). 
 
Figure 1.3. Typical signal of a trifluoromethyl group in 19F-NMR in macroscopically oriented 
samples containing CF3-labeled peptide. The chemical shift anisotropy component (δCSA) moves 
the signal away from the isotropic position (δiso). The signal is a triplet with an orientation 
dependent splitting ∆ due to the dipolar coupling between the three chemically equivalent 
fluorine atoms. 
 
1.2.3. Antimicrobial peptide gramicidin S 
 
 Gramicidin S (GS) is an antimicrobial peptide first isolated in 1943 from the 
soil bacterium Aneurinibacillus migulanus (former Bacillus brevis)31. It possesses 
high activity against Gram-positive bacteria, and is modestly active against Gram-
negative bacteria as well some fungi32,33. It shows also high hemolytic activity, 
which prevents its broad use in medicine. GS is one of the well-studied 
antimicrobial peptides, as by the year of 2012 the number of papers referring to 
gramicidin S exceeds 1000.  
The structure of gramicidin S is cyclo[Val-Orn-Leu-DPhe-Pro]2 as shown on 
Fig. 1.4. Kato and Izumiya postulated that the amphiphilic sidedness of GS is 
essential for its membrane binding34: leucine and valine residues constitute the 
hydrophobic face, and charged ornithine residues the hydrophilic side of the 
molecule. This amphipathic structure correlates with the amphipathic profile of 
lipid membranes and was indeed experimentally confirmed35,36. In GS the Pro-DPhe 
sequences form two β-turn type-II` structure, which enables the molecule to 
become cyclic. The two Val-Orn-Leu chains form an antiparallel β-sheet, where 
Val and Leu form four intra-molecular hydrogen bonds. 
The mechanism of the toxic action is still not quite clear, and optimization of 
its cell selectivity is still a subject of discussion in many biophysical37,38,39 and 
chemical40,41,42,43 studies. 
- 20 - 40 - 60 - 80 - 100 δ, ppm      
δiso 




Figure 1.4. Structure of gramicidin S: chemical (left), spatial (right), illustrating the sidedness of 
the amphipathic molecule. 
 
1.2.4. Cell penetrating peptide SAP 
 
 The cell penetrating peptide SAP (“sweet arrow peptide”) was designed in 
200444. The sequence of the N-terminal repetitive domain (Val-His-Leu-Pro-Pro-
Pro)8 of the maize γ-zein protein was taken as a template, and the hydrophilic 
residues as well as the peptide length were waried in a systematic study. The 
sequence (Val-Arg-Leu-Pro-Pro-Pro)3 showed the highest uptake by HeLa cells 
and no cytotoxicity up to very high concentrations (about 1 mM). Thus, this 
sequence (named SAP) was postulated to be an optimal cell penetrating peptide. 
SAP belongs to the proline-reach peptide family45, which undergoes an 
equilibrium in solution between a poly-L-proline type II helix (PPII) and random 
coil conformations. When SAP is structured as PPII, the three arginines are located 
on the same face of the helix such that the molecule gets amphipathic. At high 
concentrations PPII helices can assemble to cylindrical micelles. This kind of 
assembly is also important for the parent zein protein for the protein body 
biogenesis 46. 
 
1.3. Fluorine labeled amino acids for structural investigations of membrane 
active peptides 
 
 To determine the structures of MAPs in lipid membranes, the fluorine 
labeled amino acids should be introduced into the peptide sequence with the least 
possible perturbations. Several hydrophobic 19F-substituted amino acids have been 
applied for labeling Leu, Ile, Val, Ala and Met. They represent different 



















































 First, 4-fluorophenylglycine (FPhg) was applied47,48. This amino acid has a 
phenyl ring serving as a linker between the α-carbon and the fluorine atom. The 
linker provides a rigid attachment of the label to the peptide backbone, which is a 
fundamental prerequisite for the method to work. However, the chemical shift of 
the fluorine atom in this case depends not only on the macroscopic orientation of 
the C-F bond, but also on the rotameric state of the phenyl ring. Also, precise 
chemical shift referencing in solid state NMR is a tough task49. 
Such complications were overcome by changing the reporter from a single 
fluorine to a trifluoromethyl group, by introducing trifluoromethylphenylglycine 
(TfmPhg)50. The trifluoromethyl group undergoes fast rotation along the C-CF3 
bond, thus any conformational changes in the side chain do not contribute to the 
label anisotropy. The dipolar splitting of a CF3-group delivers the same information 
as the CSA, but it does not require referencing. Unfortunately, phenylglycine 
residues suffer from significant racemization during Fmoc peptide synthesis 
(normally Hünig base is employed for amino acids couplings). 
The racemization problem was solved by changing the linker type, as 
bicyclo[1.1.1]pentane was taken instead of the phenyl ring. The amino acid 
TfmBpg was specially designed and synthesized for such structural studies51. 
Chemically, it behaves like a normal α-amino acid, without significant increase of 
the α-CH acidity, and thus no racemization. Hence, it was successfully used for 











Ser   R = H
Thr   R = CH3
 
 Several other amino acids were also used for specific labeling of peptides. 
Trifluoromethylalanine (TfmAla)53 was used for labeling in place of 
aminoisobutiric acid (Aib) in the Aib-rich peptide alamethicin54. Incorporation of 
these amino acids imposes a synthetical challenge. Both TfmAla and Aib are 
quaternal amino acids. Also, in TfmAla both functional groups suffer from 
significant deactivation in peptide synthesis due to the electron withdrawing nature 
of the CF3-group. Introduction of this amino acid into a peptide was not a trivial 
task but it was solved in the following way. The TfmAla residue was first 
incorporated in the middle position of a tripeptide, which was used as a building 
block in the solid state peptide synthesis (SPPS) of alamethicin analogues. Both 
(R)- and (S)-forms  of TfmAla were applied, since the parent amino acid Aib is 
non-chiral. This trick provided some additional information in solid state NMR 
studies (twice more labels). 
 Another amino acid, trifluoromethyl-aminohydroxycyclobutanecarboxylic 
acid (TfmAhc), was recently developed as a 19F-label to replace serine (Ser) and 
threonine (Thr). It was used in place of serine in the antimicrobial peptide temporin 
 14
A55, as well as in antimicrobial peptides from the magainin family (PGLa and 
magainin 2)56. 
 Recently the labeling of peptides with trifluoromethylated amino acids, 
including their synthesis and solid state 19F-NMR results, was discussed in a 
comprehensive review57. It is also worth mentioning that peptide labeling has to be 
done with caution: non-natural structures are introduced into peptide sequences 
eventually delivering peptides different from the original one. Conformational and 
activity studies should therefore be done for each of the labeled peptide analogues 
in order to ensure that the wild type peptide structure and function are maintained. 
 
1.4. Structure and properties of proline residue in peptides and proteins 
 
 Among all proteinogenic amino acids, proline (Pro) possesses several unique 
properties. In fact, it is an imino acid with very different propensities for secondary 
structures than common α-amino acids58,59. Namely, it does not support an α-helix 
and therefore is most often being found in turns (kinks and loops), in polyproline II 
structures, as well as at the ends of regular α-helices and β-strands. 
Proline ring is already conformationally restricted such that the φ angle is 
fixed around -60°. A proline conformation is normally described in terms of exo- 















Substitutients in the ring can significantly shift the equilibrium between the 
two puckers,61,62 such that an anchoring can be achieved. This fact has significant 
impact on the cis-trans isomerization rate of the corresponding amide bond, a 
significant issue for protein folding in general63,64,65 and specifically for the stability 
of the polyproline II helix in collagen66,67. Cis-trans isomerization of prolyl 
residues plays a key role in protein folding because of the enormously low reaction 
rate of this process (much slower as for any other natural amino acid). In contrast 
to the rest of canonical α-amino acids, proline enables cis-peptide bonds to occupy 
up to 5-50% of the total population in unstructured protein parts 68. 
In nature the peptide bond isomerization of an N-acylated proline is 
controlled by chaperone of the class peptidyl prolyl cis/trans isomerases (PPIase)69. 
These enzymes attract significant attention. For instance, Pin1 mediates 
phosphorylation dependent signaling and is supposed to play a pivotal role in the 
development of cancer, Alzheimer and other age related human diseases70. PrsA 
was shown to be essential in the biosynthesis of penicillin binding proteins in 
Bacillus subtilis
71. In the plant Arabidopsis thaliana, over-expression of the ROF2 
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enzyme significantly modulates intracellular pH and causes tolerance of the cell to 
various inorganic toxic ions72. 
 
1.5. Synthesis of trifluoromethylated proline related structures 
 
1.5.1. Proline related structures 
 
Several amino acids reported in the literature can be proposed for a proline 
substitution in peptides. First of all, commercially available 4-fluoroprolines can be 
used to label a peptide with fluorine. However, it was already mentioned that the 
use of a CF3-group rather than a single fluorine offers significant advantage for the 
solid state NMR methodology. Also, the conformational restriction in the amino 
acid side chain has to be considered. Significant rigidity is an essential property to 
be able to calculate the peptide orientation from the NMR spectral parameters. 
Hence various trifluormethylated prolines or proline related structures (the closest 
structural analogues) should be considered as the labels of choice. Also the size of 
the CF3-moiety makes it a good anchor for fixing the pyrrolidine cycle in one 
particular conformation. 
This chapter discusses the current literature concerning the synthesis of 
different trifluoromethylated prolines and similar structures. Five related skeletons 
will be considered: proline (Pro), hydroxyproline (Hyp), pyroglutamic (Pyr), 
pipecolic acid (Pip) and azetidinecarboxylic acid (Aze). A few of these were found 
to occure in natural peptide sequences as well as Pro. Transformation of Hyp and 
Pyr in proline can be done synthetically and/or enzymatically. Pipecolic 
(homoproline) and azetidinecarboxylic (norproline) acids can be considered as a 
substitutients for proline, both being the closest structurally related analogues of 


















1.5.2. Structures trifluoromethylated at position two 
 
The synthetic approaches are mostly based on the synthesis of linear α-
trifluoromethylated structures, followed by formation of the C(5)-N bond to 
achieve cyclization to the proline 5-membered ring. 
2-Tfm substituted proline (2-TfmPro) was first reported in 200673 (Scheme 
1.1). The key intermediate was the corresponding allylated morpholinone 1, which 
first was synthesed from N-Boc-(R)-phenylglycinol in a multigram scale with 67% 
yield and a diastereomeric ratio (R,S):(R,R) = 3:1. The allyl substutient was 
transformed into the terminal alcohol 2 in 90% yield by oxidative hydroboration. 
The cyclyzation was achieved either by substitution with iodine or by mesyl 
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activation. The resulting diastereomeric byciclic products were separated by silica 
gel column chromatography to give two (S)- and (R)-isomers 3 and 4 in 45% and 
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Scheme 1.1. Synthesis of 2-TfmPro and 2-TfmPyr in chiral forms. 
 
Another method of proline ring closure upon iodocyclization was described 
by the same group later74. Treatment with iodine under optimized conditions (in 
pure dichloromethane) gave the four stereoisomers 5 (87% total yield), which were 
then separated. The iodine atom was removed by hydrogenolysis with palladium 
catalysys in 52% and 25% yields for the (S)- and (R)-derivatives 3 and 4, 
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respectively. The amino acids were eventually obtained upon stronger 
hydrogenolysis to yield enantiomerically pure (S)- and (R)-2-TfmPro (68% and 
45% yields). 
The same terminal alcohol intermediate 2 was used to get α-
trifluoromethylated pyroglutamic acid as well. Remove of the protecting group, 
followed by Jones oxidation, gave 2-TfmPyr in 31% yield and with the same 50% 
ee. The inverted procedure allowed resolution of the diastereomers prior to 
oxydation by selective crystallization. This procedure gave 61% yield for (R,S)-6 
and 20% for (R,R)-7.  The compounds were hydrogenated and isomeric (S)- and 
(R)-TfmPyr were obtained in 49% and 69% yields, respectively. These residues 
were later introduced into dipeptides at the N-terminal position using an optimized 
protocol75, demonstrating the use in peptide synthesis. 
Racemic 2-TfmPyr was first described in 199076 (Scheme 1.2.). Methyl 
trifluoropyruvate 8 was transformed into the corresponding imine 9 (60% yield), 
followed by a Grignard reaction with but-3-enylmagnesiumbromide (73% yield). 
Oxidation of the terminal double bond in 10 by acidic permanganate gave 96% of 
methyl ester 11, which was then saponificated (99% yield). After hydrogenolysis, 






























Scheme 1.2. Synthesis of 2-TfmPyr in the racemic form. 
 
The resulting 2-TfmPyr has been used for synthesis of tripeptides, where the 
amino acid was introduced at the N-terminal position77. The activity of the 
carboxylic group in α-alkylated peptides is known to be reduced. The synthesis was 
therefore performed with prolonged reaction time and with 4-5 fold excess of the 
amino acid at the coupling step.  
The synthetic pathway towards racemic 2-TfmHyp is shown in Scheme 
1.378. Product of the cycloaddition reaction 12 gave the desired amino acid upon 
hydrolysis in 68% yield.  
The synthesis of the dehydro analogues of 2-TfmPro and 2-TfmPip in 
nonchiral forms is presented in scheme 1.479. The Grignard reaction (54-75% 
yields) followed by alkylation of the nitrogen atom using sodium hydride in DMF 
(55-81% yields) and the ring closure methathesis reaction, gave the protected 
amino acids 13 with 5-membered (n = 0, m = 1) ring in 45-50% and 6-membered 





























n = 0, 1, 2 F3C CO2Me
NHPG
MgBr



















Scheme 1.4. Synthesis of the dehydro analogues of 2-TfmPro and 2-TfmPip in the racemic form. 
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Scheme 1.5. Synthesis of the amides and peptides with 2-TfmPro and 2-TfmPip residues via 
multicomponent Ugi reaction. 
 
An approach towards short peptide sequences with 2-TfmPro and 2-TfmPip 
in the N-terminus was recently described80. The key transformation was the 
multicomponent Ugi reaction with the corresponding trifluoromethyl-1-pyrroline 
14 (Scheme 1.5.). A number of amides were achieved in relatively high yields, and 
peptides in medium to high yields. 
 
1.5.3. Structures trifluoromethylated at position three 
 
Several approaches towards 3-TfmPyr were established in the 1990s 
(summarized on Scheme 1.6.). All of them used a Michael addition of glycine 
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Scheme 1.6. Synthetic approaches towards isomeric 3-TfmPyr. 
 
The first approach81 used the pinen derivative 16 which gave the Michael 
adduct 17 as mixture of four isomers, with the ratio 
52(cis):31(trans):13(cis):4(trans) and 63% overall yield. The first two 
diastereomers were successfully separated by column chromatography. 
The second approach82 with the benzophenon derivative 18 yielded in an 
optimized procedure (with sodium hydroxide in the condensation and citric acid on 
the hydrolysis steps) only the racemic trans-diastereomer (95% overall yield). The 
enantiomeric mixture was resolved by an α-chemotrypsin (α-CT) assisted 
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hydrolysis of the ethyl esters (65% conversion), giving the (2S,3S)-isomer 20 in 
high and the (2R,3R)-isomer 21 in medium purity. The latter substance was finally 
purified by crystallization of its ethyl ester (17% chemical yield). Hydrolysis of the 
corresponding ethyl ester 22 gave the free (2R,3R)-amino acid (95%  yield). 
The third approach83 used the chiral complex 23 of Ni(II) with the Schiff 
base of glycine and (S)-o-[N-(N-benzylprolyl)amino]benzophenone ((S)-BPB).  
The Michael addition was done in dimethylformamide using 1,8-
diazobicycloundec-7-ene (DBU) as a base. The resulting adducts showed only the 
(S)-configuration of the 2-C atom. Two epimers of the position 3, 24 and 25 in a 
ratio 5.6:1.0, were obtained as a mixture (78% yield). From the mixture the 
(S)(2S,3S)-isomer 24 was obtained in pure form in 65% yield simply by washing 
with diethyl ether. The ether fraction was chromatographically separated to give 
(S)(2S,3R)-25 and (S)(2S,3S)-24 in 11% and 5% isolated yields, respectively. 
Hydrolysis of the ethyl esters gave the corresponding 3-TfmPyr isomers (85-87% 
yields). The chiral auxiliary (S)-BPB was extracted with chloroform from the 
obtained amino acids; the recovery was 93-95%. 
 
1.5.4. Structures trifluoromethylated in position four 
 
All three structures, 4-TfmPro, 4-TfmPyr and 4-TfmHyp, are well known 
and some of them can be cross-converted. 
The synthesis of 4-TfmHyp and its conversion into 4-TfmPro is shown on 
Scheme 1.784. First, the methyl ester of trans-Hyp 26 was protected with a Boc 
group, and the hydroxyl was oxidized with trichloroisocyanuric acid (TCCA) using 
TEMPO ((2,2,6,6-tetramethylpiperidin-1-yl)oxyl) free radical catalysis (88% 
yield). The protected prolinone 27 was treated with the Ruppert-Prakash reagent to 
give the 4-TfmHyp derivative 28 as a single diastereomer in 56% yield. The 
carboxyl group was reduced with sodium borohydride (94% yield). The resulting 
carbinol was protected with a silyl type protection group (89% yield) and 
dehydrated (76% yield). The key enamide intermediate 29 was then hydrogenated 
under palladium for the double bond reduction (78% yield) to give only the cis-
isomer 30 in > 98% de. Finally, the hydroxymethyl group was oxidized (94% 
yield) to give Boc-4-cis-TfmPro. 
The key enamide 29 was also deprotected (85% yield) and reduced with an 
Ir-cyclooctadiene complex to give 31 (91% yield). This procedure enabled 
inversion of the reaction diastereoselectivity. Boc-4-trans-TfmPro was obtained 






















































Scheme 1.7. Synthesis of the isomeric N-Boc 4-Tfm-(S)-Pro. 
 
A similar but shorter procedure was used for the synthesis of 4-cis-Tfm-(S)-
Pro85 (Scheme 1.8.). The protected prolinone 32 was obtained in 38% overall yield 
starting from Hyp. It was treated with the Ruppert-Prakash reagent to yield 81% of 
the 4-TfmHyp derivative 33. Dehydration (78% yield) followed by hydrogenation 
of the resulting double bond under palladium (90% yield) gave Boc-4-cis-Tfm-(S)-






























Scheme 1.8. Synthesis of chiral N-Boc 4-cis-Tfm-(S)-Pro. 
 
A completely different approach towards 4-Tfm-(R)-Pro was published by 
the same authors86 (Scheme 1.9.). Here, the trifluoromethyl group was installed 
first, and then the proline ring was constructed.  First, the trifluoromethylated 
acroleate derivative 34 was synthesized from Garner’s aldehyde in two steps (not 
shown). The double bond was reduced by hydrogenolysis (94% yield), the 
protection groups were changed in three steps (64% overall yield), and two 
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diastereomers 35 were separated chromatographically to give the pure (2R,4R)- 
and (2R,4S)-isomers in the ratio of 4:3. After deprotection (91% and 99% yields, 
respectively) the proline ring was constructed by an energetically favorable 5-exo-
tet intramolecular alkylation (80% and 83% yields), the silyl-protection group was 
removed quantitatively. Finally, the hydroxymethyl group was oxidized with the 
Jones reagent (68% and 56% yields) to give the corresponding (2R,4R)- and 














































Scheme 1.9. Synthesis of the isomeric 4-Tfm-(R)-Pro. 
 
Another method which involves the intramolecular cyclization is presented 
in Scheme 1.1087. 1-Trifluoromethylvinyllithium 36 was reacted with para-
methoxybenzyl (PMB) protected (S)-hydroxymethyloxirane. The hydroxyl group 
was exchanged to tosylamine (45% yield in four steps). The resulting compound 37 
underwent an intramolecular unfavorable 5-endo-trig cyclization by heating with 
potassium hydroxide in ethyleneglycol (68%). The product 38 was enriched with 
















Ar = Ph   trans:cis = 92:8
























Scheme 1.10. Synthesis of the N-tosylated 4-TfmPro. 
 
The organolithium reagent 36 also reacted with aryl-oxiranes as well as the 
trimethylsilyl derivative 39 with aryl-aldehydes, and eventually the aryl derivatives 
40 were cyclized in the same way. The de was 86 and 80 for phenyl and 2,4-
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dimethoxyphenyl pyrrolidines, respectively (85% and 74% chemical yields). The 
aryl groups in 41 were oxidized in 45% and 72% yield to give the non-chiral 
diastereomerically enriched Ts-TfmPro.  
Oxydation of 4-TfmPro to the corresponding 4-TfmPyr with sodium 
periodate/ruthenium (IV) oxide was also described88. Type of the functional group 
protection played a key role in this case. 
 
1.5.5. Structures trifluoromethylated at ω-position 
 
5-Tfm-thioproline (2-(trifluoromethyl)-1,3-thiazolidine-4-carboxylic acid) 
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Scheme 1.11. Synthetic approach towards 6-Tfm-(S)-Pip. 
 
6-TfmPip (ω-Tfm-homoproline) was synthesized recently90 (Scheme 1.11.). 
The key intermediate β-amino ketal 42 was obtained starting from ω,ω,ω-
trifluorpent-3-en-2-on 43 and (+)-phenylethylamine in 57% yield as an equimolar 
mixture of diastereomers. However, the chiral substitutient enabled the separation 
of the isomers on silica gel. The benzyl protection group was removed by 
hydrogenolysis (95% yield). The formed (R)-amine 44 was also synthesized 
alternatively, starting from trifluoroacetaldehyde methyl hemiacetal 45 in four 
steps (52% overall yield). This intermediate was condensed with ethyl glyoxalate, 
giving the mixture of cis- and trans-cyclic amino acids 46 and 47 in 70% de and 
65% chemical yield. The 1,3-dioxin ring in 46 was transformed into a methylene 
group by consecutive dithioketolation (96% yield) and desulfurization of the 
dithiolane with Raney nickel (90% yield).  
4-cis-TfmAze was described recently91. The synthesis was based on the 
cyclization of ω,ω,ω-trifluoromethyl-β-aminobutyric acid. The carboxylic group 




1.5.6. Trifluoromethylated methanoprolines 
 
 A few structures were specifically developed to place a CF3-label onto 
proline in peptides92. They are based on the corresponding 3,4- and 4,5-






































Scheme 1.12. Synthetic approach towards isomeric TfmMePro. 
 
 The key step was in both cases a trifluoromethylation of the corresponding 
dehydroprolines 48 and 49 with trifluorodiazoethane. Isomeric Tfm-3,4-MePro was 
obtained in relatively poor chemical yield, whereas the Tfm-4,5-MePro synthesis 
was more successful. Three isomers, the so-called A- B- and C-Tfm-4,5-MePro, 
were obtained. Finally, A-Tfm-4,5-MePro was introduced into the cell penetrating 
peptide SAP by standard SPPS, where it demonstrated prominent stabilization of 
















2. Aims of this study 
 
The main aim of this work was to examine the conformational influence of 
different proline analogues when placed into peptides. This included some amino 
acids with only minor modifications (like monofluoroprolines) but covered also 
some rather complex structures (like different methanoprolines). At the same time, 
rather simple commercially available compounds were used, as well as a few of 
synthetically highly demanding novel structures. 
 Proline is never inert towards modifications. Any changes in its structure will 
influence the conformational and functional properties of the resulting peptides. In 
order to reveal these changes and understand the risks of proline labeling, the 
present study systematically compares a wide range of available and novel 
analogues. 
 Two different peptide structures were chosen as templates for the proline 
substitution. In the antimicrobial peptide gramicidin S (cyclo[VOLDFP]2) proline is 
rigidly enclosed in a β-turn. The cell penetrating peptide SAP ([VRLPPP]3), on the 
other hand is conformationally very sensitive to amino acid substitutions, because a 
random coil to PPII equilibrium takes place. Gramicidin S is only modestly water 
soluble, thus its functionality is highly sensitive to unspecific changes in 
hydrophobicity. In contrast, the highly charged SAP is perfectly water soluble. The 
amino acid position 11 in SAP, where proline was systematically substituted, is 
located on the hydrophilic face of the amphipathic PPII structure. Therefore, 
unspecific effects of the proline analogues unlikely to play a role in the aggregation 
and assembly of this peptide. 
 In summary, the aims of this work were as follows: 
 
- To synthesize various proline analogues in a suitable form for peptide 
synthesis. To verify, and if needed to modify the available synthetic 
procedures for this purpose; 
- To synthesize the linear peptide SAP and the cyclic peptide gramicidin S 
with the proline analogues. To check the compatibility of the chosen amino 
acids with the common solid phase peptide synthesis protocol and (for 
gramicidin S) other synthetic steps; 
- To perform a thorough conformational analysis of the resulting peptides 
using circular dichroism; 
- To perform biological activity tests with the antimicrobial gramicidin S 
analogues, in order to reveal and understand the unspecific and specific 
impacts of the different proline substitutions; 
- To study the fluorine-labele MAPs using solid state NMR in oriented lipid 
samples and answer the questions: how does the spectral response look like 
for different peptides labeled with different 19F-NMR reporter groups? 
Which experimental protocol is better, and how to perform the most 
informative spectral analysis? 
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- To understand whether there is a relationship between peptide function and 
conformation, and what may cause such response; 
- To come to a final conclusion on how to chose a sutable proline analogue for 
labeling a peptide with a 19F-NMR reporter group? Which amino acids are 
recommended, and what is the optimal protocol to incorporate them? How to 
minimize the conformational and functional impact in the study of native 
peptide structures? Or how to maximize these effects in the design of novel 
peptide structures? 
 
In the following sections 3 (Results) and 4 (Discussion), a comprehensive 
answer on the above questions will be given. Step by step, from method to method 
the findings will be assembled, in order to give a final complete picture. 



































First a number of different amino acids were chosen for incorporation into 
peptides instead of proline. The list of the amino acids and used nomenclature are 
summarized in Table 3.1. Chemical synthesis of the amino acids in the form 
suitable for the peptide synthesis will be described in the chapters 3.1-3.3. Chapter 
3.4. will be dedicated to the synthetic incorporation of the amino acids into 
gramicidin S and SAP. Studied properties of the resulting peptides will be 
described in the chapters 3.5-3.6. (GS) and 3.7.-3.8. (SAP). 
 
# amino acid name* structure 

































































                                                 












Table 3.1. Amino acids used in this study for proline substitution. 
 
Few rows for further comparison can be extracted out of the full amino acids 
list: 
1) different degree of conformational restriction (flp/Flp vs TfmPro; TfmPro vs 
TfmMePro; F2Pro vs F2MePro); 
2) different stereochemistry (flp vs Flp; c-MePro vs t-MePro; c-TfmMePro vs t-
TfmMePro; c-F2MePro vs t-F2MePro); 
3) different degree of fluorination (MePro vs flp/Flp vs F2Pro/F2MePro vs 
TfmPro/TfmMePro); 
4) different electronic effects of the substitutients (MePro vs TfmMePro vs 
F2MePro). 
 
3.1. Geminal difluoro-4,5-methanoproline 
 
3.1.1. Amino acid synthesis 
 
The novel amino acid t-F2MePro was synthesized starting from 4,5-
dehydroproline derivative 50 which was obtained in three steps starting from 
pyroglutamic acid (Scheme 3.1)93. 
1. MeOH/SOCl2
2. Boc2O, CH3CN,
    DMAP
1. LiBHEt3, THF, -78°C, 2h
2. DIPEA, DMAP, TFAA,
    -78 to RT, 16h
3. H2O









Scheme 3.1. Synthesis of the protected 4,5-dehydroproline (50). 
 
Difluorocyclopropanation was done using thermal decomposition of 
ClF2CO2Na salt in refluxing diglyme
94. Temperature in bath was kept strictly in the 
range 175-180°C (overheat above 185°C led to decomposition of the material) for 
20-45 min reaction time, the solvent was then removed in vacuum and the crude 
material was subjected directly to silica gel separation (Scheme 3.2). Single  
compound was obtained. Only traces of the starting dehydroproline were detected. 
The yield varied depending on how the salt was added: 31% in the case when 7 eq. 
of the salt was added to the enamide before heating, 58% when only 1/3 of the 
same 7 eq. was added before heating and the rest 2/3 was added already at the high 
temperature, and 71% when 15 eq. of the salt was added at once at the high 
temperature. Resulting Boc-t-F2MePro-OMe 51 was then saponificated giving the 
Boc-amino acid Boc-t-F2MePro-OH 52. The crystal structure (Fig. 3.1) determined 
52 being trans-methano isomer.  
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It turned out that Boc-deprotection of both the methyl ester Boc-t-F2MePro-
OMe and the acid Boc-t-F2MePro-OH with trifluoroacetic acid in dichloromethane 
at room temperature led to full decomposition of the material. There was no major 
product detected in the orange water soluble residue formed. Decomposition of 
geminal F2-aminocyclopropane system was expected
95 but not at such conditions: 



















Scheme 3.2. Synthesis of Boc-t-F2MePro-OH. 
 
 
Figure 3.1. X-ray molecular structure of Boc-t-F2MePro-OH. 
 
In order to estimate the stability of free amino acid acetylation was done. 
Treatment of Boc-t-F2MePro-OMe with TFA/CH2Cl2 cocktail for 30 min, followed 
by quick (within 5 min) evaporation of volatilities and adding of acetic anhydride 
gave Ac-t-F2MePro-OMe in reasonably low 9% yield. For instance, for the same 
derivative of proline similar procedure96 yielded 85% of the acetylated product. 
This fact was indicating significant degree of decomposition along the performed 
procedure. 
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Resulting derivative Ac-t-F2MePro-OMe (as well as the starting Boc-t-
F2MePro-OMe) was stable at room temperature at least for several months. 
 
3.1.2. Kinetic of t-F2MePro decomposition in N-deprotected form 
 
 Three substances were generated and followed by 19F/1H-NMR: TFA*H-t-
F2MePro-OMe (in CDCl3), TFA*H-t-F2MePro-OH and H-t-F2MePro-OH (both in 
D2O). 
 
3.1.2.1. Decomposition of the trifluoroacetic salt of H-t-F2MePro-OMe in 
chloroform 
 
Boc-t-F2MePro-OMe was treated with trifluoroacetic acid in CHCl3 (1:2 vol) 
for 15 min. The time delay between addition of TFA and the spectra acquisition 
was 30 min. 
The spectrum at the beginning showed presence of both TFA*H-t-F2MePro-
OMe salt and the starting Boc-t-F2MePro-OMe in the ratio ~ 5:1
*. The intensities 
of the two characteristic doublets seen in the 19F-NMR spectra at -129.2 (exo-F) 
and -148.0 ppm (endo-F†) with JF-F= 178Hz were steady decreasing along the time 
as presented on Fig. 3.2. Linearization in the coordinates lnI-time and 1/I-time 
(where I is the intensity value of the exo-F signal) gave correlation coefficient 
square 0.979 and 0.958 respectively. Therefore it was concluded that the order of 
the reaction was not an integer number. The half life time τ1/2 was about 110 min 
and the practical disappearance of the salt signals was committed after about 24 
hours of the observation.  


























 exo-F (-129.2 ppm)









Figure 3.2. Decomposition of TFA*H-t-F2MePro-OMe in CDCl3 at 23°C observed by 
19F-NMR. 
                                                 
* when the cocktail treatment time was only 5 min the ratio was lower, ~ 4:3. 
† the assignment was assumed basing on the additional splitting on protons characteristic for the down field fluorine 
signal as well as the chemical shift values themselves (see chapter 3.2.3). 
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No (prominent) product was identified in the mixture in both 1H- and 19F-
NMR spectra. Presumably, eventual evolution of F- ions during decomposition 
process in the slightly acidic medium was leading to a reaction of hydrofluoric acid 
with the glass material of the NMR tube. This explains why the total 19F-signal was 
practically disappearing. The bands in the 1H-NMR spectra of the final mixture 
were broad and not resolved, presumably due to various condensation reactions 
happening. 
 
3.1.2.2. Decomposition of the trifluoroacetic salt of H-t-F2MePro-OH in water 
 
In order to generate the free amino acid salt Boc-t-F2MePro-OH was treated 
with the TFA/CDCl3 cocktail for 15 min and the residue was extracted with CDCl3. 
The spectrum of the extract showed almost pure starting substance. The non-
soluble in chloroform part was dissolved in deuterium oxide and a 1H/19F-NMR 
time series was launched. These operations were done within the next 25 min, the 
total time before the series start was 40 min. Two doublets attributed to the product 
TFA*H-t-F2MePro-OH in the 
19F-NMR spectrum were at -129.8 (exo-F) and -
148.3 (endo-F) with JF-F= 178Hz. The 
1H-NMR spectrum of this substance is 




















































Figure 3.3. 1H-NMR spectrum of H-t-F2MePro-OH in D2O at the beginning of the time series. 
Two singlets of the residual starting substance (Boc-rotamers) are indicated by an arrow. 
 
The ratio of the product to the starting Boc-form was ~ 10/1 at the beginning 
of the series. Corresponding signals in the fluorine spectrum decayed as presented 
on Fig. 3.4. Linearization in coordinates lnI-time and 1/I-time (where I is the peak 
intensity of the exo-F signal) gave the correlation coefficient square 0.999 and 
0.847 respectively, indicating the first order of the decomposition process (Fig. 
3.5.). The half life time τ1/2 was 39 min, and the signal was completely vanishing 
after ~ 200 min of observation. 
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Figure 3.4. Decomposition of TFA*H-t-F2MePro-OH in D2O. 





















 = 0.0158 - 0.0176*time
 
Figure 3.5. Linearization curve for the endo-F signal intensity of TFA*H-t-F2MePro-OH in D2O 
as seen in 19F-NMR. 
 
It was not possible to figure out the composition of the resulting mixture 
after 24 hours. However, few prominent signals were observed in the spectra 
during the series. Few of them showed the same evolution along the time: in 1H-
NMR d, J= 19Hz at 9.21 ppm, dt J= 32 and 7Hz at 6.31 ppm, t, J= 7Hz at 4.26 
ppm, m at 3.02 ppm and in 19F-NMR dd J= 32 and 19Hz at -131.1 ppm. Signals in 
characteristic spectral regions enabled me to deduce the structure of the additive 
being 54 (Fig. 3.6.*). The maximum of the aldehyde additive 54 population 
corresponds to the time point of disappearance the starting amino acid salt signals. 
                                                 
* slight difference between 19F and 1H curvatures on Fig. 3.6 is caused by the complicated  baseline shape in 19F 
spectra 
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Figure 3.6. Evolution of the additive signal in the TFA*H-t-F2MePro-OH decomposition series 
and its proposed structure (54). 
 
 Basing on the observations a mechanism of the F2MePro ring opening was 
proposed (Scheme 3.3.). High electrophylic atom in position 1 of the bicycle is 
being attacked by a water molecule, resulting hemiaminal 53 gives the observed 
high reactive aldehyde 54. The aldehyde as well as the hemiaminal has few 
theoretical reaction possibilities: condensation, oxidation, cycloaddition. 























Scheme 3.3. Proposed mechanism of TFA*H-t-F2MePro-OH decomposition in D2O. 
 
 Such decomposition mechanism explains the firs order of the degradation in 
excess of water. In the case of TFA*H-t-F2MePro-OMe the only one nucleophile 
present in CDCl3 solution was trifluoroacetic acid, which was in about 3-4 fold 
excess*. This explaines complex order of the degradation in this case. 
 
3.1.2.3. Decomposition of the basic form of H-t-F2MePro-OH in water 
 
However, whether the protonated forms were instable because of the acidic 
medium or deprotected form was instable intinsically was not clear. In order to 
                                                 
* the ratio was estimated from the 19F-NMR spectrum at the starting point. 
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check the stability of the base form Boc-t-F2MePro-OH was deprotected and the 
starting compound was extracted as described above. Now the salt was extra 
treated with the Hünig base (DIPEA) before the NMR executions. The total time 
from the addition of trifluoroacetic acid until the 19F-NMR spectrum was taken was 
the same 40 min as for the trifluoroacetic acid salt. There were no characteristic 
doublet signals in the expected for geminal F2 ranges neither from the basic amino 
acid nor from the TFA salt. Moreover, the major lines in the spectrum were the 
trifluoroacetic acid signal and a singlet at -122.2 ppm attributed to fluoride ions. 
This fact clearly showed that the decomposition was caused not by the acidic 
medium, but from other reasons. 
 
3.1.3. The 7,7-difluoro-2-azabicyclo[4.1.0]heptane system 
 
In order to understand the role of the bicyclic system an analog of the desired 
amino acid with a nitrogen locked in a wider six-membered ring was synthesized 
according to scheme 3.4. Resulting Boc-amine 55 was synthesized in 73% yield 
and then deprotected. The salt with trifluoroacetic acid 56 was stable in 
deuterochloroform for several months. In deuterium oxide no traces of 




















Scheme 3.4. Synthesis of the 7,7-difluoro-2-azabicyclo[4.1.0]heptane. 
 
Moreover, the salt can be transformed into corresponding amine by shaking 
with potassium carbonate solution. This free amine was stable for recording the 
basic NMR spectra. Detailed investigation of the amine stability was not provided. 
However, it was already clear that the decomposition of t-F2MePro was caused by 
the bicyclic system. Apparently, the [3.1.0]heptane system becomes unstable after 
the nitrogen changes its nybridization from sp2 in the Boc- or Ac-protected to sp3 in 
deprotected form. 
 
3.2. Dipeptides with F2MePro amino acid 
 
In order to overcome the synthetic complications and incorporate F2MePro 
amino acid into peptides, the N-deprotcted form of this amino acid must be 
completely avoided in the peptide synthesis. For this purpose 
difluorocyclopropanation was carried out with the dipeptides where the future 
peptide bond between the preceding amino acid and dehydroproline was already 








For incorporation into gramicidin S, the corresponding dipeptide with DPhe 
residue was designed and synthesized as presented on Scheme 3.5. Pyroglutamic 
acid was esterified with isobuthylene (82% yield), this protection was used to make 
the final remove of the protecting groups But and Boc in one step. DPhe residue was 
coupled to the pyroglutamate97 (89% yield) and the amide group in the resulting 
dipeptide 57 was reduced and dehydrated giving the dipeptide of 4,5-
dehydroproline 58 (76% yield). The regioselectivity of this reduction was rather 
poorly discussed in literature98, however in this work it gave only the desired 4,5-
dehydroproline derivative. 
This dipeptide was difluorocyclopropanated with sodium 
chlorodifluoroacetate. The enamide conversion turned out to be a critical point. Use 
of 15 equivalents gave mixture of the starting material and the product with the 
ratio ~ 1:1*. This mixture was practically impossible to separate by common silica 
gel chromatography. Shaking this mixture with potassium permanganate enriched 
the product content to ~ 4:1. Such purity was still not good enough for introduction 
into peptides. Use of 25 equivalents of the salt on the cyclopropanation step finally 
gave full conversion, this lead however to formation of a side product. The yields 
were 29% for the desired dipeptide 59 and 7% for the additive 60. 
Structure of the additive was deduced from the NMR data. In the 1H-NMR 
spectrum of Boc-DPhe-t-F2MePro-OBu
t the two tert-butyl groups were presented 
and the substance showed two prominent Boc-rotamer forms. In contrast, the 
additive spectrum contained only one tert-butyl group and showed marginal 
amount of rotameric forms. In the 13C-NMR spectrum of the additive normal Boc 
carbonyl signal at ~155 ppm was absent, but two new triplets were present instead 
at 158.3 (J= 31Hz) and 118.8 ppm (J= 301Hz). In the 19F-NMR an additional 
singlet was at -63.8 ppm (2F). The NMR data of the additional signals was in 
complete agreement with the literature for the ClF2C(=O)-NH group
99. The 
configurations of the product and of the additive were the same as was judged from 
heteronuclear NOE experiments (see chapter 3.2.3.). 
Apparently excess of the reacting salt acetylated the NH group in DPhe 
residue followed by elimination of the butoxycarbonyl protection. Such side 
reaction has never been reported in the literature.  
The dipeptide 59 was transformed in two steps into the corresponding Fmoc-
form 61 (in 82% yield) ready for use in the peptide synthesis. Analytical HPLC 
with UV detection of the Fmoc-DPhe-t-F2MePro-OH revealed purity of 89% (at 
220 nm) with no major additives. This substance was pure enough for the further 
gramicidin S synthesis. 
                                                 
* this was not expected since in the case of the amino acid synthesis (chapter 3.1.1) any attempts towards 51 gave 


















1. LiBHEt3, THF, -78°C
2. DIPEA, DMAP, TFAA












































Scheme 3.5. Synthesis of  Fmoc-DPhe-t-F2MePro-OH. 
 
3.2.2. Synthesis of Pro-t-F2MePro dipeptide 
 
For the incorporation into SAP in position 11 the dipeptide Pro-F2MePro was 
synthesized analogously to the DPhe dipeptide. Boc-proline was coupled to the tert-
butyl pyroglutamate in 83% yield. Reduction-dehydrataion reaction gave 
corresponding 4,5-dehydroproline derivative in 70% yield. 
This dpeptide 62 was difluorocyclopropanated according to the procedure 
established for DPhe-dipeptide with 27 equivalents of the salt (Scheme 3.5). In this 
case two isomers with t-F2MePro 63 (48% yield) and c-F2MePro 64 (10%) were 
obtained. The configuration of the isomers was determined using heteronuclear 
NOE experiments (vide infra). Quantitative separation was done by the preparative 
RP-HPLC. The dipeptides were transformed into the corresponding Fmoc-
dipeptides according to Scheme 3.4. Fmoc-Pro-t-F2MePro-OH was obtained with 
94% yield and 80% purity without any major admixture. The minor Boc-Pro-c-
F2MePro-OBu
t 64 was obtained as ~ 9:1 mixture with the major isomer (estimated 
 37
from the 19F-NMR spectra) in the preparative RP-HPLC. It was then transformed 


























Scheme 3.5. Synthesis of the Boc-Pro-c/t-F2MePro-OBu
t dipeptides. 
 
3.2.3. Configuration of F2MePro dipeptides 
 
In order to distinguish cis- and trans-isomeric forms of methano units in the 
difluorocyclopropanation products, heteronuclear 1H ↔ 19F NOE experiments were 
carried out. Eventually, the experiment with 1H irradiation and 19F observation was 
sensitive to distances up to ~ 3Å and the inverse experiment with 19F irradiation 
and 1H observation – up to ~ 4Å respectively. This latter type of transfer was 
chosen for the proceeding. Efficiency of the 19F-NMR signal suppression was 
always checked by the homonuclear 19F NOE of the same suppression power level. 
Analysis of the crystall structures available for cis- and trans-methano Boc-
4,5-MePro-OH in the Cambridge Structural Database showed that the distance 
between endo-H in methano unit and the H-2 atom should be 3.80 and 3.11 Å 
respectively100. This fact led to the expectation of a relative strong correlation 
endo-F ↔ H-2 in trans- and relative weak in cis-methano isomer of F2MePro. 
The distance H-2 ↔ H-5 in cis- and trans-4,5-MePro is 3.83 and 3.96 Å 
respectively. The difference between these type homonuclear distances in the two 
methano-isomers is rather small. Presence of some correlation between the two 
protons was observed already in t-F2MePro derivatives in NOESY indicating that 
1H1H NOESY experiment in this case can be misleading. Eventually, only 1H ↔ 
19F NOE enabled clear distinguish of the isomers. 
The 19F-NMR spectrum of the CF2 unit of all F2MePro derivatives showed a 
downfield doublet at ~ 126-132 ppm with additional splitting on protons (4-15 Hz) 
and an upfield doublet at ~ 148-155 ppm with no additional splittings. For Boc-t-
F2MePro-OH the molecular structure and full assignment of the 
1H-NMR 
spectrum* were known. In the X-ray molecular structure (Fig 3.1.) the distances 
from exo-fluorine atom to H-4 and H-5 are 2.65 and 2.63 Å respectively†, whereas 
to the rest of the protons in the range 3.86-4.84 Å. When the downfield fluorine 
was suppressed the corresponding 1H difference spectrum contained two strong 
correlations with H-4 and H-5 with relative intensities 1.3 and 1.0 respectively. 
Thus this fluorine was the exo. The endo-fluorine atom is close to almost all 
protons of the 5-membered ring, the distances to H-2, 3(endo), 3(exo), 4 and 5 are 
                                                 
* from 1H1H-COSY and 1H13C-HMQC NMR spectra. 
† all the X-ray molecular structure distances should be taken into consideration with the warning that X-ray 
structures show distances between centers of the electron densities and NMR shows distance between nuclei. 
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3.22, 2.59, 3.77, 3.23 and 3.25 Å respectively. Corresponding relative integrals in 
1H difference NOE were 0.93, 0.92, 0.27, 0.88 and 1.00. The strong correlation 
between H-2 and endo-F was expected for the trans-methano isomer. It was indeed 
observed. The assignment of exo/endo-fluorine atoms was extrapolated for all 
F2MePro containing compounds basing on their similar patterns in the 
corresponding 19F-NMR spectra: an upfield pure doublet for endo-F and a 
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Figure 3.7. 1H-NMR spectrum of Boc-t-F2MePro-OH with assignment. The spectrum shows 
presence of rotameric forms. 
 
Compound  relative integral 
 α-CH H-5 H-4 
Boc-t-F2MePro-OH exo-F - 1.00 1.28 




exo-F - 1.00 1.45 




exo-F 0.05 1.00 1.07 




exo-F - 1.00 1.43 




exo-F - 1.00 1.71 




exo-F - 1.00 1.48 
endo-F 0.96 (2) 1.00 3.99 
ClF2C(=O)-
DPhe-(t)-F2MePro-OBu
t exo-F - 1.00 1.27 
endo-F 1.02 (2) 1.00 3.91 
Fmoc-Pro-(t)-F2MePro-OH 
Major 
exo-F 0.14 1.00 1.14 
endo-F 2.38 1.00 3.77 
Fmoc-DPhe-(t)-F2MePro-OH 
Major 
exo-F - 1.00 1.21 
endo-F 2.11 1.00 4.86 
Table 3.2. Relative integral values in the 1H-NMR difference spectra recorded with irradiation of 
the corresponding fluorine atom and without. The integral value for the full α-CH range are 
given, unless (2) marks the integrals only for α-CH in F2MePro residue (H-2). Few large values 




The heteronuclear NOE difference spectra (Table 3.2) of Boc-Pro-F2MePro-
OBut showed integrals 1.45 and 1.00 for the major and 1.42 and 1.00 for the minor 
isomer for H-4 and H-5 in the case of exo-F irradiation. These values can be 
considered to be practically the same since the geometry of the cyclopropane ring 
is expected to be the same in both isomers. Correlation in the case of endo-fluorine 
irradiation with the protons from the α-CH range was 1.27 and 0.20 respectively if 
correlation with H-5 was taken as 1.00. This was a prominent difference, it 
indicated that the major isomer was trans and the minor was cis.  
 
 
Figure 3.8. Molecular structure of the minor isomer Boc-Pro-c-F2MePro-OBu
t. 
 
Despite an additional correlation was found between the endo-F atom and 
CH-2 of the proline residue, the absence of a strong correlation in the α-CH 
spectral region with endo-F, in the case of the minor isomer proofs, it being the cis-
isomer. Finally those conclusions were confirmed with the X-ray molecular 
structure analysis of the minor Boc-Pro-c-F2MePro-OBu
t (Fig. 3.8). 
This prominent difference in the correlations between endo-F and α-CH was 
also found for Pro-F2MePro-OBu
t dipeptides which were obtained after partial 
deprotection of the Boc-protected dipeptides.  
In contrast to the proline dipeptide, both products of the DPhe dipeptide 
synthesis showed the same strong correlation between endo-F and H-2. The 
observation confirmed them possessing the same configuration. Finally the major 
dipeptides in the Fmoc-form showed similar strong correlation endo-F ↔ H-2. 
It is worth mentioning that the conclusions of the substances configurations 
were consistent with the [α]D values. Namely, all cis-methano isomers showed 
prominent shift towards positive values in comparison with the values from the 
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Scheme 3.6. Syntheses of Boc-F2Pro-OMe and Boc-TfmPro-OMe starting from hydroxyproline. 
 
Incorporation of amino acids into peptide sequences with manual Fmoc 
SPPS strategy requires corresponding amino acids in Fmoc-Xaa-OH form. flp and 
Flp were bought already as Fmoc-protected. Boc-F2Pro-OMe 65 was synthesized 
according to101 starting from hydroxyproline (Scheme 3.6.). Boc-TfmPro-OMe was 
obtained starting from the same compound according to synthetic protocol at 
Scheme 1.8. which was however modified as shown on Scheme 3.6. First 4-
oxoproline derivative 27 was obtained from hydroxyproline in two steps in 73% 
yield. It was treated with the Ruppert-Prakash reagent to give the adduct 28 in 77% 
yield. Water molecule was eliminated with thionyl chloride in pyridine giving 66 in 
77% yield. Finally, hydrogenolysis under palladium catalyst gave desired protected 
amino acid 67 (94% yield). 
The two TfmMePro amino acids were synthesized according to Scheme 
1.13. starting from protected dehydroproline (Scheme 3.1.) by cyclopropanation 
with trifluorodiasoethane. Despite the procedure was performed according to the 
protocol and conversion of the dehydroproline was full, problems on the 
chromatographic separation step appeared. Only two A- and B-forms (c- and t-) of 
Boc-TfmMePro-OMe were eluted from the column with 8.9 and 8.5% yields 
respectively. That was about 3 fold less in comparison to the original protocol. 
However, amount of the c- and t-TfmMePro in Boc-Xaa-OMe forms was enough 
to provide further syntheses. 
The rest of the amino acid was available as Boc-cis-MePro and HCl*trans-
MePro. All the amino acids were successfully transformed in the Fmoc-protected 

















Scheme 3.7. General scheme for the Fmoc protection of the amino acids for the peptide 
synthesis. 
 
3.4. Peptide synthesis 
 
3.4.1. Synthesis of proline substituted gramicidin S analogues 
 
Gramicidin S (GS) analogues with different fluorine labeled and 
conformationaly restricted amino acids were synthesized. GS is the cyclic 
decapeptide composed out of head to tail pentapeptides. Hence there are two 
substitution possibilities for a single mutation: 
1. one residue = single (asymmetric) substitution, 
2. both residues = double (symmetric) substitution. 
The GS synthesis was performed according to the previously published in our 
group protocol102. It was however modified during the synthesis implementation 
according to the latest observations103.  
The original protocol was as following. The linear peptide was synthesized on a 
chlorotrytyl resin starting from the DPhe residue providing corresponding linear 
decapeptides: 




Resulting linear decapeptides were cleaved from the resin with a TFA-based 
cocktail, precipitated from diethylether, cyclized in solution (dichloromethane) 
under high dilution conditions. The ornitine residues were deprotected with 
hydrazine in tetrahydrofurane. The product was subjected to the preparative RP-
HPLC. This protocol was further modified.  
First of all the protection group of the ornitines was changed from the 
expensive ivDde to a cheaper Boc. The linear decapeptides were cleaved from the 
chlorotrytyl resin by a milder hexafluoroisopropanol/dichloromethane cocktail 
where the Boc-N moieties remain intact. The product was not precepitated but 
directly cyclized in the diluted solution in dichloromethane, then deprotected with 
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the TFA based cocktail, precipitated and RP-HPLC purified. In this case the 
product was already quite clean and easier to separate. 
To avoid the unexplored cyclization DPhe-Xaa, for the double substituted GS 
the synthesis was started from Val such that the cyclization was a more predictable. 
Precipitation at the end of the synthesis was also not very efficient since 
reasonable amount of the matherial was dissolved in ether. For the most 
hydrophobic peptides, amount of compounds in ether fraction was higher than was 
precipitating. Both, the residue and the ether solution were taken for purification. 

























Table 3.3. List of the proline synthesized substituted GS analogues. 
 
3.4.2. Synthesis of leucine substituted gramicidin S analogues 
 
In order to provide the material for further planned investigations of GS 
behavior in lipid membranes, few other analogues were synthesized. Namely, 
phenylglycine (Phg) and para-fluorophenylglycine (FPhg) were introduced at 
leucine positions, from which the first was used for double substitution only and 
the second for both single and double (Table 3.4.).  
The amino acids were bought as zwitter-ions in racemic forms (as the 
racemization along the synthesis was assumed to be very likely) and transformed 
into corresponding Fmoc-derivatives suitable for the peptide synthesis using Fmoc-
Cl reagent. The peptide synthesis was done the same way as described in the 
previous chapter starting from DPhe-preloaded chlorotrytyl resin. The peptides 
were synthesized in a mixture of D- and L-labeled forms which were then 
separated on the preparative RP-HPLC. Assignment of the chromatogram was done 
according to the observation that each one DFPhg causes significant shift of the 
retention time to lower values48. The assignment was consistent with the circular 
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dichroism measurements of obtained fractions (D-amino acids invert the elipticity 
and thus decreas the absolute signal intensity).  
 
name Sequence 
I-DFPhg-GS cyclo[Val-Orn-DFPhg-DPhe-Pro -Val-Orn-Leu-DPhe-Pro] 
I-LPhg-GS cyclo[Val-Orn-LFPhg-DPhe-Pro -Val-Orn-Leu-DPhe-Pro] 
II-D,DFPhg-GS cyclo[Val-Orn-DFPhg-DPhe-Pro -Val-Orn-DFPhg-DPhe-Pro] 




II-D,DPhg-GS cyclo[Val-Orn-DPhg-DPhe-Pro -Val-Orn-DPhg-DPhe-Pro] 
II-D,LPhg-GS cyclo[Val-Orn-DPhg-DPhe-Pro -Val-Orn-LPhg-DPhe-Pro] 
II-L,LPhg-GS cyclo[Val-Orn-LPhg-DPhe-Pro -Val-Orn-LPhg-DPhe-Pro] 
Table 3.4. List of the synthesized leucine substituted GS analogues. 
 
3.4.3. Synthesis of proline substituted SAP analogues 
 
A row of SAP analogues was synthesized (Table 3.5.), where proline residue 
in position 11 was substituted with the artificial amino acids. The synthesis was 
performed according to44, starting from proline preloaded chlorotrytyl resin. 
Arginine was loaded in the Pbf-protected form. The only change in the reactants 
was the coupling reagent 6Cl-HOBt instead of HOAt.  
 
Name Sequence cleavage 
SAP-TfmPro VRLPPPVRLP-TfmPro-PVRLPPP HFIP 
SAP-c-MePro VRLPPPVRLP-c-MePro-PVRLPPP HFIP 
SAP-t-MePro VRLPPPVRLP-t-MePro-PVRLPPP TFA 
SAP-flp VRLPPPVRLP-flp -PVRLPPP TFA 
SAP-Flp VRLPPPVRLP-Flp-PVRLPPP TFA 
SAP-A(c) VRLPPPVRLP-c-TfmMePro-PVRLPPP * 
SAP-B(t) VRLPPPVRLP-t-TfmMePro-PVRLPPP HFIP 
SAP-t-F2MePro VRLPPPVRLP-t-F2MePro-PVRLPPP TFA 
SAP-c-F2MePro VRLPPPVRLP-c-F2MePro-PVRLPPP HFIP 
Table 3.5. List of the synthesized SAP analogues. The last column represents the cocktail type 
used for cleavage of the peptide from the resin. Asterisk indicates the peptide synthesiyed 
previously by Dr. Mykhailiuk104. 
 
For the first few synthesized analogues the cleavage and the deprotection 
steps were separated in order to make a proper monitoring. First the linear peptide 
was cleaved from the resin with hexafluoroisopropanol/dichloromethane cocktail 
and the tris-Pbf-protected peptide was treated with the TFA-water mixture in the 
volume ratios 95:5 and 80:20105. 
According to the HPLC monitoring, the first employed cocktail showed 
absence of all protection groups after one hour and the second one gave not 
complete deprotection even after 2 hours of treatment. After this observation the 
cleavage from the resin for the rest of peptides was done with the TFA-water 95:5 
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cocktail directly. The full list of the synthesized analogues is presented in the Table 
3.5. 
 
3.4.4. Synthesis of the peptides with F2MePro 
 
Both I-t-F2MePro-GS and SAP-t-F2MePro were synthesized as usual. The 
Fmoc-dipeptides were taken as 2 eq, whereas the rest of the amino acids as 4 eq 
(for GS) and 6 eq (for SAP). Normal 2 hour coupling time was prolonged for the 
dipeptide coupling to 4-5 h and for the next amino acid to 3 h. However careful 
HPLC monitoring showed that such prolongation was even not necessary. 
Cycliyzation of the GS analogue was done as usual. Resulting peptides were 
obtained in pure forms in 20% and 34% yields for I-t-F2MePro-GS and SAP-t-
F2MePro respectively. 
Synthesis of SAP-c-F2MePro was done the same way as for the 
corresponding trans-analogue, except of the 3 times less loading and the lower 
purity of the starting Fmoc-dipeptide (see chapter 3.2.2.). Here the coupling was 
complete after 3 hours. After coupling of the next amino acid (Pro) and at the end 
of the sequence grow the chromatogram showed two main products. Previously 
few diastereomeric SAP peptides labeled with rac-FPhg were not possible to 
separate on corresponding D- and L- forms with RP-HPLC106. The peaks on the 
chromatogram are usually broad. Hence the strategy was changed. 
First the linear tris-Pbf peptide was cleaved from the resin with the HFIP 
cocktail, the compound in contrast to the deprotected form was rather hydrophobic 
than amphiphilic, thus showed narrower peaks in chromatogram. The two products 
were separated by RP-HPLC, deprotected with the TFA-water (95:5 vol) cocktail* 
and purified by RP-HPLC again. The major peptide obtained this way was pure 
(7% yield) and showed characteristic 19F-NMR spectrum with two doublets 
different by chemical shifts than of the t-F2MePro substituted peptide (see Table 
7.2). 
 
3.5. Properties of the gramicidin S analogues 
 
3.5.1. Hydrophobicity (RP-HPLC) 
 
First the GS analogs were systematically compared by retention times in 
analytical RP-HPLC. This is a normal part of the purity characterization of the 
peptides after the synthesis. However, the retention time reflects also the 
hydrophobicity of the corresponding substances. 
Systematic analysis of the terention time values showed few tendencies (Fig. 
3.9.). For the proline substituted analogues, each single fluorination (Flp and flp 
substitution) decreases the hydrophobicity of resulting peptides, whereas 
trifluoromethylation (TfmPro, c/t-TfmMePro) increases it. The rest of the peptides 
                                                 
* the deprotection was complete within 30-60 min period according to the HPLC monitoring. 
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from this group (substituted with F2Pro, c-MePro, t-F2MePro) showed only slight 











































































































































Leu substituted Pro substituted








Figure 3.9. RP-HPLC retention times of the studied GS analogues.  
 
The influence of the proline substitutient is rather non-specific in contrast to 
the leucine substitution. Introduction of a phynylglycine residue decreases the 
hydrophobicity and exceed impact of fluorination. Inversion of L-Phg or FPhg to 
respective D-configuration has the strongest effect, causing dramatic reduction of 
the retention times. This effect can be easily explained as disruption of the 
amphipathic profile of the molecule. 
 
3.5.2 Antimicrobial activity (MIC) 
 
Antimicrobial activity of the GS analogues was compared in serial 2-fold 
broth dilution test with both Gram-positive and Gram-negative bacterial strains107. 
This test shows the ability of the substances to inhibit the bacterial grow in a given 
medium. The bacteriostatic activity correlates with the ability of the tested peptides 
to kill bacrerial cells. Gravimetrically determined peptide concentration is known 
to be not very accurate. Therefore the peptide amounts were calibrated on HPLC 
and then corrected by aliquotizing from the stock solutions with known 
concentrations. The values of minimal inhibitory concentration (MIC) obtained 
thereafter are presented in Table 3.6. 
All the synthesised GS analogues maintain the antimicrobial activity with 
differend degree of decrease. In the case of proline substitution few tendencies can 
be extracted from the MIC data. Single fluorination (flp and Flp) retains the 
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activity almost on the level of the wild type peptide. In contrast, 
trifluoromethylation (TfmPro, c/t-TfmMePro) decreases the activity especially in 
the case of double substitution. Double F2Pro substitution does it as well. The rest 
of the proline substituted GSs showed values of the activity 1-3 dilution less then 
the wild type. 
For leucine labeling decrease of the antimicrobial activity against Gram-
positive strains is caused by introduction of D-residue (main effect) and a 
Phg/FPhg instead of leucine (minor effect).  
 










wild type  ≤0.5 2 16 64 
Pro substitution 
II-Flp 1 8 16 128 
II-flp 1 4 32 128 
I-Flp 1 8 16 128 
I-flp ≤0.5 2 16 128 
I-F2Pro 1 2 32 256 
I-c-MePro 1 4 32 128 
I-t-F2MePro 1 2 32 128 
II-c-MePro 2 4 64 128 
II-F2Pro 8 16 256 128 
I-TfmPro 2 4 64 128 
I-A(c) 4 4 128 128 
I-B(t) 8 8 256 128 
II-TfmPro 16 16 > 256 256 
II-A(c) 64 32 > 256 128 
II-B(t) 64 64 > 256 > 256 
Leu substitution 
II-D,DPhg 64 64 128 128 
II-D,DFPhg 64 > 64 128 64 
II-D,LPhg 32 32 64 128 
II-D,LFPhg 8 32 64 128 
I-DFPhg 8 64 32 256 
II-L,LFPhg 2 4 64 256 
II-L,LPhg 2 8 128 > 256 
I-LFPhg 1 2 16 64 
Table 3.6. Minimal inhibitory concentration (MIC) of the GS analogues determined in the serial 








3.5.3. Conformation (CD) 
 
Circular dichroism (CD) is a versatile spectroscopic method videly is used to 
study conformation of peptides in solution108,109. Gramicidin S is cyclic and 
therefore possesses a relatively rigid secondary structure. The structure is 
additionally stabilized by four intermolecular hydrogen bonds. The CD spectra in a 
hydrogen bond preserving solvent such as trifluorethanol (TFE) and in a protic 
solvent such as water might be different. This is indeed observed (Fig. 3.10.). The 
spectrum contains two prominent negative bands: at 206 and 223 nm110. The band 
ratio changes upon changing the solvent as shown at Fig. 3.11. 

























Figure 3.10. Circular dichroism spectra of the wild type gramicidin S in water (solid line) and 













































































































































Leu substituted Pro substituted
 
Figure 3.11. [θ]223/[θ]206 elipticitiy ratios determined in CD spectra of the gramicidin S 
analogues in trifluorethanol (grey boxes) and water (white patterned boxes) at 25°C. 
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The leucine substituted analogues showed the largest differences between the 
elipticity ratios in the two solvents when the D-residues content was increased. The 
GS structure is significantly affected by D-amino acids content. 
For the group of proline substituted peptides additional measurements were 
done in (12:0/12:0)PC (DLPC) unilamellar vesicles. First the wild type peptide was 
measured in phosphate buffer (PB) and in PB-methanol mixture (1:1 vol). The 
elipticity at 215 nm was taken as the value to indicate the signal intensity. 
GS is a peptide modestly soluble in water. The signal intensity in PB was 
only 0.27 of that in PB-methanol. The intensity rose to about 0.8 of the PB-
methanol value when the peptide was mixed to DLPC liposomes. It remained 
practically the same when the lipid and the peptide were codissolved before the 
vesicles preparation rather than mixed. This apparent equality indicates high 
affinity of GS to an amphipathic lipid interface. 
The most hydrophobic analogues II-A(c)-GS and II-B(t)-GS showed no 
spectrum in PB meaning they are not soluble in this solvent at all. The binding to 
the DLPC liposomes led to transfer of the peptide in solution and increase of the 
signal. The observed signal increase was slow (Fig. 3.12.). Measured instantly after 
mixing the signal intensity was only 0.1 of the signal intensity in reconstituted 
samples for both II-A(c)-GS and II-B(t)-GS. Being monitored over prolonged time 
the intensity steady increased during few hours of observation (Fig 3.12.) and after 
10 h reached 0.9 intensity of the reconstituted sample. 
For the most hydrophophilic ones II-Flp-GS and II-flp-GS this ratio was 0.9 
already after mixing with the liposomes indicating immediate immobilization as 
was for the wild type. For the rest of the proline substituted peptides the starting 





























































































Figure 3.12. Intensity of the signal at 215 nm in the CD spectrum of hydrophobic II-A(c)-GS in 
various enviroments related to the intensity in PB-methanol solution (taken as 1.0) at 30°C and 
37 mM nominal peptide concentration. In DLPC samples the peptide to lipid ratio was 1/40. 
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It was said that the elipticities ratio [θ]223/[θ]206 for the wild type GS in water 
was substantially increased (0.82) in comparison to TFE (0.63). In lipid vesicles 
this ratio was even higher 0.92. In PB-methanol this ratio was practically the same 
as in water. The ratio [θ]223/[θ]206 in this solvent mixture was compared against the 
band ratio in DLPC reconstituted samples as shown on Fig. 3.13. The peptides with 
methanoprolines in trans-configuration (I-t-F2MePro-GS, I-B(t)-GS and II-B(t)-
GS) demonstrated systematically higher [θ]223/[θ]206 values. Moreover for all of 
them as well as for II-flp-GS the ratio remained almost the same in solution and in 





















































































Figure 3.13. [θ]223/[θ]206 elipticities ratios in CD spectra of the gramicidin S analogues in PB-
methanol solution (white patterned) in presence of DLPC vesicles (grey) at 30°C and 37 mM 
nominal peptide concentration. The peptide to lipid ratio was 1/40. 
 
All the other amino acids were showing rather moderate and less systematic 
levels of conformational changes. However, all the gramicidin S peptides showed 
similar shapes of the CD spectra, showing that the rigid GS structure was not 
significantly disturbed. 
 
3.5.4. Hemolytic activity (HC50) 
 
Lytic activity against human erytrocites of selected GS analogues was 
measured. The 50% hemolytic concentrations for the proline substituted GS 
peptides are illustrated at Fig. 3.14. For all peptides containing single fluorinated 
amino acids the level of hemolysis decreased whereas for the rest of the amino 
acids the effect was opposite. The highest hemolysis was observed for double 
trifluormethylated peptides. The degree of hemolysis was higher for II-A(c)-GS < 
II-TfmPro-GS < II-B(t)-GS.  
GS analogues containing two FPhg residues were previously investigated111. 
It was shown that hemolysis decreased in the order L,L > wild type GS >> L,D >> 
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D,D. Here the effect of a single leucine with FPhg replacement was studied (Fig. 
3.15.). The activity decreased in the order II-L,LFPhg ≥ II-L,LPhg > I-LFPhg > wild 
type GS. Thus data is consistent with the previous observation that II-L,LFPhg-GS 
possesses higher hemolytic activity then the wild type peptide. On the other hand 
the activity was almost the same for II-L,LPhg-GS and II-L,LFPhg-GS suggesting no 






















































































Figure 3.14. 50% hemolytic concentrations determined for the proline substituted GS analogues. 

































Figure 3.15. Hemolytic activity of leucine substituted GS analogues containing L-epimers. 
 
 51
3.6. Solid state NMR of GS analogues in lipid membranes 
 
Solid state NMR of the GS analogues in macroscopically oriented lipid 
bilayers was done. Herein orientational behavior of selected peptides is described. 
In the following description the oriented samples were aligned parallel to the 
magnetic field unless other stated. 
 
3.6.1. FPhg substituted peptides 
 
 
Figure 3.16. Solid state 19F-NMR spectra of II-L,LFPhg-GS in (14:0/14:0)PC at p/l = 1/40. Dotted 
square indicates the re-aligned signals. 
 
As was already described in the literature II-L,LFPhg-GS (denoted LGS by 
the autors) demonstrated a specific orientational behavior in (14:0/14:0)PC 
(DMPC) at peptide to lipid ratio (p/l) up to 1/80112. In a temperature dependent 
series of 19F-NMR spectra, at the temperatures far from the main gel-to-liquid-
crystalline lipid phase transition (Tm) the fluorine signal was at the upfield side of 
the CSA tensor and at the temperature close to the main phase transition (Tm ~ 
23°C) new signals appeared at the downfield side, regardless of whether the 
temperature was changed in cooling or heating mode. After the analysis the upfield 
singlet was attributed to the surface peptide alignment and the downfield (so-called 
re-aligned) signal was assigned as a state when the GS molecule is immersed in the 
lipid bilayer. The same re-alignment of LGS was observed in this work as shown 
on Fig. 3.16. 
An analysis was proposed113 in which different regions of the spectra were 
integrated and the normalized integrals were plotted against the temperature (as 
shown on Fig. 3.17.). It turned out that corresponding mono substituted peptide I-







LFPhg-GS showed barely visible degree of re-alignment at the same conditions 
where II-L,LFPhg-GS showed almost 80% of the re-aligned state. 




























Figure 3.17. Analysis of II-L,LFPhg-GS and I-LFPhg-GS re-alignment in DMPC (p/l = 1/40). 
Circles – the re-aligned fraction (-67; -104ppm) in the 19F-NMR spectra (-67; -136ppm) of II-
L,LFPhg-GS, triangles – the re-aligned fraction (-75; -102ppm) in the spectra (-75; -131ppm) of I-
LFPhg-GS. 























Figure 3.18. Analysis of II-L,LFPhg-GS and I-LFPhg-GS re-alignment in DLPC at p/l = 1/40. 
Circles – the re-alignment fraction (-62; -100ppm) in the 19F-NMR spectra (-62; -125ppm) of II-
L,LFPhg-GS, triangles –the re-aligned fraction (-63; -101ppm) in the spectra (-63; -125ppm) of I-
LFPhg-GS. 
 
In a shorter DLPC lipid the degree of the re-orientation and the 
corresponding temperature range was known to be higher and broader for LGS. 
The main thermotropic phase transition in this lipid takes place at -2°C the re-
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alignment of LGS happened in the temperature range +25 ÷ -10°C. For the mono 
labeled molecule I-LFPhg-GS this range was smaller +15 ÷ -7°C (Fig. 3.18.). 
Finally, II-D,DFPhg-GS in DMPC oriented bilayers showed two peaks in the 
spectrum above the phase transition (35°C) at -105 (sharp) an -114 ppm (broad). 
This indicated completely different mode of alignment with two states of the 




Few samples of II-B(t)-GS in DMPC at p/l = 1/40 were investigated within 
both heating and cooling series with a step of 1°C in the focus (phase transition) 
temperature range. Corresponding 19F-NMR spectra showed broad +5.5 kHz triplet 
at the lower temperatures and narrow +4.6 kHz triplet at the higher temperatures 
with a transition around 25°C (Fig. 3.19., left stack). Apparently, there was no re-
aligned state detected upon these conditions. The peptides mobility was different in 
the gel and fluid lipid bilayer phases. In the fluid phase the triplet becomes 1 kHz 
smaller and the components become resolved and narrow.  
At higher concentration p/l = 1/20 two additional signals appear from both 
sides of the main triplet at the temperature close to the lipid phase transition (Fig. 
3.19., central stack). Addition of cholesterol (5%) caused appearance of the same 
signals already in the lamellar ordered state, and at ~ 25°C only an additional non-
resoluted component at the higher field remained (Fig. 3.19., right stack).  
In mixture with non-fluorineted analogue of LGS (II-L,LPhg-GS) the proline 
substituted II-B(t)-GS showed much higher degree of re-orientation as illustrated 
on Fig. 3.20. The total p/l ratio was taken as 1/30 and then the peptides ratio was 
varied. At the peptides ratio 1:1 (left spectrum) the re-oriented signal was a tripled 
with the constant -6.7 kHz (dashed square), its population at 22°C was 37% of the 
total signal. In the sample where II-L,LPhg-GS dominated (peptides ratio 4:1) the 
intensity of this signal reached 49% (right spectrum). In a parallel sample where II-
B(t)-GS was mixed with the wild type GS as 1:1 (the p/l ratio was the same 1/30) 
no additional triplets were observed. 
In contrast to the DMPC situation, in DLPC II-B(t)-GS completely re-
aligned in the temperature range +7 ÷ -4°C (Fig. 3.21., left stack). At higher 
temperatures there was one triplet +4.6 kHz, the re-aligned signal was a single -3.7 
kHz triplet and at the lower temperatures the splitting was +5.7 kHz. This behavior 
independent from the direction of the temperature change (cooling or heating) was 
observed if the lowest temperature in the series did not reach -10°C. 
If the series when a pre-incubation at -20°C preceded the acquisition series in 
the heating mode, the data showed prominent hysteresis (Fig. 3.21., right stack). In 
the range -10 ÷ -20°C the signal had powder-like shape. Upon heating at -5 ÷ +1°C 





Figure 3.19. Solid state 19F-NMR spectra of II-B(t)-GS in oriented lipid bilayers within heating temperature series: left stack – in DMPC at p/l = 



























Figure 3.21.  Solid state 19F-NMR spectra of II-B(t)-GS in DLPC oriented bilayers (p/l = 1/40) at different temperatures upon cooling (left stack) 
and heating (right stack). 











After reaching +1°C the spectral become the same as was in the cooling 
cycle: -3.7 kHz splitting persisted up to 5°C followed by the triplet +4.6 kHz. 
The re-alignment in DLPC was concentration dependent. The threshold 
concentration was estimated as p/l = 1/400. At p/l = 1/500 the signal evolution was 
devoid of the re-aligned state, resembling the situation observed previously in 
DMPC: single triplets 5.7 and 4.6 kHz below and above 1°C respectively. The re-
aligned signal in diluted samples with p/l = 1/200 or 1/400 was slightly different 




Corresponding mono substituted analogue I-B(t)-GS was measured in 
DMPC and DLPC samples at p/l = 1/40. In DMPC at lower temperatures the 19F-
NMR spectrum contained one triplet +5.5 kHz. This splitting value remained 
unchanged upon crossing gel to liquid crystalline phase transition of the lipid. 
In DLPC the triplet at higher temperatures (+20°C) was +5.5 kHz, upon 
cooling the re-aligned state appeared as triplet with -4.3 kHz constant. At -20°C the 
signal was powder like and upon heating the state with two triplets  +13 and -7.4 
kHz was observed first, then after 1°C the signal was ~ -3 kHz triplet and after 
further heating the +5.6 kHz triplet restored. In diluted sample in DLPC (p/l = 
1/400) the re-oriented signal was -4.7 kHz. 
The only difference observed in the spectra of I-B(t)-GS in comparison with 
its double substituted analogue was the splitting at high temperatures which in this 




II-A(c)-GS in DMPC at p/l = 1/40 showed no re-alignment. The only one 
triplet observed in the 19F-NMR spectrum was +5.5 kHz in gel (+10 ÷ +24°C) and 
+4.6 kHz in the fluid phase (up from +25°C). 
In DLPC at p/l = 1/40 in the cooling series there was only one triplet +4.7 
kHz at higher temperatures (+20 ÷ +7°C). The re-aligned state was a triplet -4.8 
kHz (+5 ÷ +1°C). Down from this temperature a triplet +5.5 kHz was present until 
-10°C, and at even lower temperatures the broad powder-like spectrum was 
observed. In the heating series a triplet -6.5 kHz appeared first (at -5 ÷ 0°C) and up 
to +5°C it drifted to -4.2 kHz, then up from 7°C the spectrum contained purely the 
high temperature triplet +4.6 kHz. 
In corresponding diluted sample in DLPC (p/l = 1/400) the triplet of the re-
aligned state was -4.5 kHz. 
 
The splitting data for all TfmMePro substituted GS peptides is summarized 
in Table 3.7. The spectra at 90° orientation of the sample to the magnetic field 
showed that in the fluid lipid phase the peptides were fast rotating along the 






gel state fluid state cooling series heating series after pre-

























~ -3 +5.6 
II-A(c) +5.5 +4.6 +5.5 -4.8 
(-4.5) 
+4.6 -6.5 -4.2 +4.6 
I-A(c) +5.9 +5.7 ~ +6 -4.8 +5.7 -6.5 -4.4 +5.5 
Table 3.7. Splitting constants in 19F-NMR spectra of GS analogues substituted with TfmMePro 
in DMPC and DLPC at p/l = 1/40 (in parentheses the values for diluted samples, p/l = 1/400) at 
different peptide states. 
 
3.6.5. II-TfmPro-GS and I-TfmPro-GS 
 
Both TfmPro substituted GS peptides were investigated in the above 
mentioned lipids. The splitting constants of the triplet signals for both peptides are 
given in Table 3.8. 
I-TfmPro-GS in DMPC (p/l = 1/40) showed a singlet shape below the phase 
transition temperature and a triplet above the phase transition with the splitting 
constant +2.8 kHz ÷ +3.2 kHz at +30 ÷ +45°C. In  DLPC (p/l = 1/40) in the cooling 
cycle the triplet well above the phase transition (+20°C) was +3.2 kHz, in the re-







fluid state cooling series heating series 

















I-TfmPro 0 +2.8 +3.2 0 -1.7 +3.2 (-5) -1.7 +3.1 
II-TfmPro 0 +1.6 +2.2 0 -6.3 +2.3 -7 -6.1 +2.3 
Table 3.8. Splitting constants for triplets in 19F-NMR spectra of GS analogues substituted with 
TfmPro in DMPC and DLPC at p/l = 1/40 within different temperature series. 
 
In the heating cycle there was a powder-like spectral shape in the frozen state 
(-20 ÷ -10°C), which then transformed into a not resolved triplet with ~ -5kHz 
constant. After +1°C the signal become a normal re-oriented triplet with the -





The most hydrophilic of the proline substituted GS analogues II-Flp-GS 
showed in general quite similar behavior to the other proline substituted peptides. 
However it took a while before the correct read out was invented.  
In the FPgh substituted peptides the fluorine chemical shift changed in a 
substantially big range. This enabled use of the normalized integrals for 
quantification of the acquired data assuming different spectral ranges for different 
peptide states. In Flp substituted peptides this was not possible. It turned out that 
the signals of the high temperature and the re-aligned states differed only slightly, 
within ~ 8 ppm. This value lays in the order of the band width. Therefore, the 
chemical shift change was analyzed rather than the integral intensity. The spectra 
were acquired in corresponding temperature series with small temperature steps, 
the data was processes using high line broadening (1.5 kHz) and the main chemical 
shift was plotted against the temperature as shown on Fig. 3.22. 






















Figure 3.22. Temperature dependence of the chemical shift in the solid state 19F-NMR spectra of 
II-Flp-GS reconstituted in DMPC (circles) and DLPC (squares) at p/l = 1/40 samples in cooling 
(filled dots) and heating (empty dots) series. 
 
In DMPC the signal changed slightly at 24-25°C upon gel to liquid 
crystalline phase transition of the lipid without any re-oriented state in both cooling 
and heating performed series. In DLPC in the cooling cycle the re-orientation was 
in the same width temperature range +7 ÷ +1°C, shifted from that demonstrated by 
the CF3-labeled peptides, presumably, due to the other type of the analysis. After 
reaching -20°C in the heating series the signal showed complicated development 





The flp double substituted peptide II-flp-GS in DLPC possessed even less 
different chemical shift (≤ 3ppm) in the re-aligned state in comparison to the signal 
in the fluid lipid phase (high temperatures). The spectral acquisition and analysis 
were done the same way as was described for II-Flp-GS. Two curves for the II-flp-
GS/DLPC 1/40 sample are shown on Fig. 3.23. 
In the cooling temperature series the re-aligned state appeared as a slight 
downfield shift of the signal in the +7 ÷ 0°C temperature range. Below, in the gel 
state of the lipid, the 19F-NMR band was very broad, the band width on the half 
high was > 5 kHz, which correspond to ~ 10 in ppm units. The chemical shift read 
out becomes not accurate in gel, such that the chemical plotting is no longer 
reliable in this lipid phase. The same broad signal was observed upon heating from 
-20°C up to 4°C. Up from this temperature the chemical shift development 
resembled corresponding situation in the cooling series (shown on Fig. 3.23. as 
“end of hysteresis”).  





















end of the hysteresis
 
Figure 3.23. Solid state 19F-NMR main chemical shift of II-flp-GS in DLPC at p/l = 1/40, 
dependence from the temperature in cooling (filled squares) and heating (empty squares) cycles. 
 
3.6.7. Peptides with geminal F2 system in solid state NMR 
 
Non-rotating geminal difluor system was complicated for observation in 
solid state 19F-NMR experiments, such that the spectral acquisition and the data 
analysis became not trivial. Due to the presence of a strong geminal coupling 
between unequivalent fluorine nuclei and strong interaction with the 1H nuclei in 
corresponding proline cycles, the free induction decay of the 19F signal was 
complete in less than 1 ms in the fluid lipid and 200 µs in the gel lipid phase. The 
spectral lines were broad and therefore the number of scans was substantially 
increased in order to get the spectra of the same quality as for a CF3 labeled 
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peptide. Other acquisition parameters such as spectral window and the pulse if not 
optimized caused significant distortion of the spectral line shape.  
Upon adjusted conditions, II-F2Pro-GS in both DLPC and DMPC showed a 
good resoluted characteristic spectrum only above the phase transition (fluid 
phase). In gel as well as in the re-aligned state conditions the spectrum was very 
broad (the band width at the half high was > 80kHz) and not resolved (Fig. 3. 24., 
left stack), such that the analysis  was impossible. The same behavior showed its 
mono substituted analogue I-F2Pro-GS (not shown). 
19F-NMR spectra of I-F2MePro-GS with two fluorine atoms rigidly attached 
to the amino acid were narrower and better resolved. As shown on Fig. 3.24. (right 
stack) the signal in gel and fluid lipid phases appears at the same spectral position 
whereas the re-aligned spectrum appeared at the upfield side of the CSA tensor 
with the band width at the half high ~ 25 kHz.  
 
 
Figure 3.24. Solid state 19F-NMR spectra of and II-F2Pro-GS (left stack) and I-t-F2MePro-GS 
(right stack) in DLPC oriented bilayers at p/l = 1/40.  
 
 The line shape in the 19F-NMR spectra at high temperature (fluid lipid phase) 
can be considered as two doublets originating from the two unequivalent fluorine 
atoms of the CF2 groups. In the 
19F-NMR of F2MePro residue (Fig. 3.25.) the two 
signals stand 33 ppm apart (in solution the distance between two 19F-NMR 
resonances was 25 ppm), strong dipole dipole interaction between that two 
fluorines causes the doublet shape for each of them with the 10 kHz coupling 
constant. The doublet shape is distorted such that the inner components have lower 
intensity as the outer. This secondary effect can be called “inverted roof”: if the 
two fluorine atoms had the same chemical shift the two signals would merge in a 
doublet in solid state NMR, in contrast to liquid state NMR where the merge will 
lead to a singlet line shape causing the common roof effect.  










Figure 3.25. Solid state 19F-NMR spectrum of I-t-F2MePro-GS in DLPC oriented sample (p/l = 
1/40) at 20°C (fluid lipid phase). 
 
  In the case of II-F2Pro-GS the spectrum in the fluid lipid phase is composed 
from the two doublets with ~4.5 kHz coupling, 14 ppm apart. The signal has a 
triplet like appearance because the distance between two doublets and the splitting 
are of the same strength. In the corresponding spectra at 90 degree sample 
orientation the dipolar coupling became twice shorter (~2 kHz), and the chemical 
shift distance remained the same. 
 




31P-NMR spectra of the oriented samples were acquired before and after the 
19F-NMR measurements, hydratation, re-hydratation or long sample storage in 
freezer. They were done well above the main phase transition temperature in order 
to control the degree of orientation and mosaic spread of the samples. On Fig. 3.26. 
the 31P-NMR spectra of the II-B(t)-GS containing samples are shown as 
representative examples.  
Typically, the band width at the half high was 200-300 Hz for the DLPC and 
300-400 Hz for the DMPC samples. In the appled field strength (11.7 T) these 
values correspond to a 1-2 ppm width, whereas the size of the full tensor measured 
in multilamellar vesicles was about 45 ppm. Thus the mosaic spread could be 
estimated on the level of several degrees which is good enough for the oriented 
samples. 
Presence of the peptides did not change neither the mosaic spread nor the 
degree of the lipid headgroups orientation as was judged from corresponding 31P-
NMR spectra. Several times after the samples were kept long time at the 
temperatures below 0°C a huge perpendicularly oriented part (15-20%) appeared in 
δ, ppm - 50  - 100  - 150  - 200  - 250  
33 ppm 
10 kHz 10 kHz 
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the spectra of the diluted samples in DLPC (p/l 1/200 or 1/400). Systematic studies 
of this effect gave controversial results and the effect was assumed to be casual. 
Figure 3.26. Solid state 31P-NMR spectra of the oriented samples containing II-B(t)-GS 
reconstituted in different lipids. The spectra were acquired at 35°C for DMPC and 30°C for 
DLPC (in the liquid crystalline lipid phase). 
 
The GS analogues re-alignment described above was observed near the main 
phase transition temperature of the lipid by 19F-NMR. Corresponding 31P-NMR 
temperature series were carried out in order to find whether the peptide re-
alignment correlates with any changes in the lipid headgroups orientation or 
mobility. First samples with pure DMPC and DMPC containing GS peptides (at p/l 
= 1/40) were measured. The peptides of different re-orientation propensity were 
taken to make a proper comparison: II-L,LFPhg-GS (high re-alignment), I-LFPhg-
GS (marginal re-alignment), II-B(t)-GS (no re-alignment) and the wild type GS 
(unknown re-alignment). Neither of the peptides caused any substantial changes in 
the spectra other than those can be attributed to the lipid phase transition. However, 
closer look revealed slight deviation of the chemical shift temperature dependence 
(Fig. 3.27.). Namely, the 31P-NMR chemical shift drifted almost linearly along the 
temperature change for the pure lipid. II-L,LFPhg-GS containing sample showed 
visible deviation from this behavior: the chemical shift was shifted upfield in the 
temperature range +19 ÷ +22°C in comparison to all other samples, such that the 
corresponding curve has characteristic “dimple”. 
The same peptides were taken for testing the phosphorus chemical shift 
changes in DLPC oriented samples. In this lipid the peptides re-aligned in the 
temperature ranges +25 ÷ -10°C for II-L,LFPhg-GS, +15 ÷ -10°C for I-LFPhg-GS 
and +7 ÷ -4°C for II-B(t)-GS. Corresponding temperature dependences of the 31P 
chemical shifts for the samples contained these peptides as well as with the wild 
type GS and the control sample with pure DLPC sample are given on Fig. 3.28. 
The upfield shift caused by the presence of the peptides was more prominent as in 
DMPC, the “dimple” was of 3-5 ppm size. The starting temperature of the upfield 
δ, ppm  50   0  - 50  δ, ppm  50   0  - 50  
DMPC 
p/l = 1/20 
DMPC 
p/l = 1/40 
DMPC 
+ 5% cholesterol 
p/l = 1/40 
DLPC 
p/l = 1/40 
DLPC 
p/l = 1/200 
DLPC 
p/l = 1/400 
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shifts was different and correlated with the re-alignment propensities of the 
peptides: +13 for II-L,LFPhg-GS, +5 for I-LFPhg-GS and -1°C for II-B(t)-GS. 



























Figure 3.27. Temperature dependence of the 31P-NMR chemical shift in oriented samples of 
DMPC with (p/l = 1/40) or without peptides. 
 













  wild type GS













Figure 3.28. Temperature dependence of the 31P-NMR chemical shift in oriented samples of 
DLPC with (p/l = 1/40) or without peptides. 
 
This observation leads to the conclusion that the peptide re-alignment 
process is indeed connected to the changes in the lipid headgroup state. The 
correlation between the re-alignment observed by the 19F-NMR and the upfield 
drift in the 31P-NMR is prominent and allows indirect monitoring of the re-
orientation propensity for non-fluorinated peptides such as the wild type GS.  
Corresponding curves of the samples with the wild type GS are very similar 
to that from the II-B(t)-GS. Apparently, proline substitution in this case gave 
minimal changes. 
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3.7. Conformational analysis of SAP analogues in solution 
 
Systematic investigation of the SAP analogues was done in water solution by 
circular dichroism (CD) measurements with synchrotron light source114. CD spectra 
of the PPII and unordered structure (random coil) are known to be similar. The 
most prominent difference between them is the elipticity at ~227 nm, where PPII 
shows has a small positive maximum, whereas the random coil has a negative 
elipticity of the same order115. The CD spectrum of SAP wild type in water has the 
signal at 227 nm close to zero. This fact shows that the solution contains both 
conformations with similar populations. Substitution of proline in position 11 with 
the amino acids from the Table 3.1. lead to significant shift of the PPII – random 
coil equilibrium. 
 
First the peptides were systematically measured at concentration 0.5 mg/ml 
(corresponds to ~ 0.25 mM) at 20°C. It was already known, that c-TfmMePro 
stabillize the PPII conformation92, it turned out that c-MePro sustained it as well, 
whereas c-F2MePro showed no stabilization as can be judged from the different 
positive intesity of the band at 227 nm (Fig. 3.29., A). On the contrary, all peptides 
with trans-methano amino acids (t-TfmMePro, t-F2MePro and t-MePro) showed 
very negative elipticities at this spectral position indicating disruption of the PPII 
structure (Fig. 3.29., B). 
Both Flp and flp did not show any significant impact on the CD shape (Fig. 
3.29., C), despite for collagen mimicking peptides67 that two amino acids showed a 
significant impact to the PPII population. 
The elipticities at 227 nm are presented separately on hystogramm (Fig.3.29., 
D). This wavelength corresponds to the positive maximum in CD spectra of SAP-
A(c) and SAP-c-MePro. Corresponding [θ]227 values were 2471 and 1915 
deg·cm2·dmol-1 respectively, close to those of pure PPII conformation. The 
negative values suggest significant contribution of the random coil structure for 
SAP-B(t), SAP-t-MePro and SAP-t-F2MePro. 
The negative maximum position in CD spectra remained almost the same for 
all peptides and varied in the range 202-203 nm and therefore not informative. 
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Figure 3.29. CD spectra of the SAP analogues in water at 20°C, concentration 0.5 mg/ml: A) SAP wild type, SAP-A(c), SAP-c-MePro, SAP-c-
F2MePro; B) SAP wild type, SAP-B(t), SAP-t-MePro, SAP-t-F2MePro; C) SAP wild type, SAP-Flp, SAP-flp, SAP-TfmPro measured in another 
series of samples. D) histogram of elipticities of SAP-11 substituted peptides at 227 nm. 
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At higher concentration 10 mg/ml (corresponds to ~ 5 mM) the positive 
maximum for the peptides with the sustained PPII structure appeared at the same 
wavelength 227 nm. Corresponding elipticities for the investigated SAP 
analogues are compared on Fig. 3.30. In fact the CD curves show three “states” 
of the petides: SAP-A(c) and SAP-c-MePro with high value for the positive 
band ([θ]227 = 2323 and 2054 deg·cm
2·dmol-1 respectively); SAP-t-F2MePro, 
SAP-B-(t) and SAP-t-MePro showed negative elipticities (-1136, -1705 and -
2321 deg·cm2·dmol-1 respectively) and the rest of the analogs possess slight 
































































































Figure 3.30. Mean residue elipticities of SAP analogues at 227 nm. The peptides were 
measured in water at 20°C at concentration 10 mg/ml.  
 
For several selected structures CD was measured in 95% n-propanol (at 
4°C and concentration 0.5 mg/ml) which is known as a solvent promoting 
formation of PPI helical conformation. Neither of the peptides, SAP wild type, 
SAP-t-F2MePro, SAP-A(c) and few others showed formation of a PPI helix 
conformation upon these conditions. Even after 2 days pre-incubation at 4°C the 
spectral shape remained unchanged. 
The measurements of the SAP wild type in phosphate buffer (pH = 6.7), 
methanol and trifluorethanol (data not shown) showed very similar curvatures 
(at concentration 0.5 mg/ml and 25°C) as in water. Apparently the peptide 







3.8. Solid state NMR of SAP analogues in lipid membranes  
 
3.8.1. TfmMePro substituted SAP analogues 
 
Both TfmMePro substituted peptides were investigated in solid state 
NMR in macrospopically oriented lipid samples. It was found that first the 
peptide shows an isotropic singlet which upon heating disappears and triplets of 
the immobilized peptide rise instead. 
A typical series of SAP-A(c) is presented on Fig. 3.31. The peptide was 
reconstituted in DMPC at p/l = 1/40 and first the 19F-NMR spectrum showed an 
isotropic signal above the phase transition of the lipid (35°C). Then the sample 
was heated up to 50°C and then a series of spectra was acquired. Intensity of the 
isotropic signal decreased and three new triplets rose instead, with +9.5, +3.7 
and -4.5 kHz splitting constants. 
 
 
Figure 3.31. Series of solid state 19F-NMR spectra of SAP-A(c) in DMPC at p/l = 1/40. The 
oriented sample was aligned parallel to the magnetic field. First a spectrum was taken at 
35°C, then three spectra (3 hours per each one) were taken at 50°C. 
 
δ, ppm  50   0  - 50  - 100  - 150  
+9.5 kHz -4.5 kHz 
+3.7 kHz 
35°C 
50°C 3 hours 
50°C 6 hours 
 
50°C 9 hours 
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The measurements were continued in (18:1/18:1)PC (DOPC) where the 
phase transition is -20°C that ensured the temperature of the measurements to be 
well above the phase transition  temperature. The characteristic spectra are 
shown on Fig. 3.32. 
 
Figure 3.32. Solid state 19F-NMR spectra of SAP-B(t) (left) and SAP-A(c) (right) in 
(18:1/18:1)PC (DOPC) at p/l = 1/40 and temperature 50°C. The samples aligned parallel 
(spectra below) and perpemdicular (spectra above) to the magnetic field. Presented triplets are 
denoted. The dotted lines indicate the isotropic signals. 
 
In contrast to SAP-A(c) peptide the SAP-B(t) always showed only one 
triplet in the corresponding 19F-NMR spectra with +9.1 kHz splitting constant. 
All the signals of SAP analogues showed -1/2 reflection in the corresponding 
90° spectra (Fig. 3.32., above), that indicated fast rotation along the lipid normal 
of the peptides for all peptide states represented by the triplets. The intensity of 
the isotropic signal increased when the samples were cooled to lower 
temperatures, but it was never coming back to the same domination as was 
before the heating. 
In order to understand the role of peptide-peptide interactions in the 
alignment of SAP analogues in the membrane environment, the SAP-A(c) was 
mixed with SAP-3E* in 1:1 ratio and these mixture was reconstitutedted in 
DOPC at total p/l = 1/40. SAP-3E was known as not stabilizing PPII 
conformation as was judged from corresponding CD measurements (data not 
shown). 
The sample was measured at 30°C and then a series of spectra was 
acquired at 50°C for two days. In this conditions the two triplets with the 
                                                 
* sequence: VELPPPVELPPPVELPPP. 












splitting constants +3.5 and -4.7 kHz showed simultaneous disappearance and 
eventually only the triplet with +10 kHz splitting remained (Fig. 3.33.).  
The result of this measurement is that presence of another peptide can 
change the states equilibrium for the observed peptide, thus an interaction 
between SAP peptides indeed takes place. Another conclusion is that two small 
triplets were presumably of the same conformational state of the peptide and the 




Figure 3.33. Solid state 19F-NMR spectra of SAP-A(c) in mixture with SAP-3E 1:1 in DOPC 
at p/l = 1/40 (ratio 1:1:80) at 30°C before (below) and after (above) two days incubation at 
50°C. The sample was aligned parallel to the magnetic field. 
 
3.8.2. TfmPro substituted SAP 
 
19F-NMR spectra of SAP-TfmPro in DMPC samples (p/l = 1/40) were 
acquired. First the spectrum at 35°C showed strong isotropic signal, which upon 
high temperature incubation disappeared and two triplets with constants +6.4 
and -3 kHz appeared instead as presented on Fig. 3.34. 
In another temperature series the same sample was heated to even higher 
temperature and then cooled down to the room temperature. The measurements 
within this temperature series showed different dominant states, the two triplets 
mixture was observed at the beginning of the series, the downdfield triplet 
dominated at 70°C and the upfield triplet with the significantly higher dipolar 
coupling constant remained after the sample was cooled down at the end. This 
was an indication that complicated peptide transition between different states 
was happening. This point requires further exploration. 










Figure 3.34. Solid state 19F-NMR spectra of SAP-TfmPro in DMPC (p/l = 1/40): three 




P-NMR spectra of the lipid oriented samples with SAP analogues 
 
In corresponding 31P-NMR spectra the samples showed good degree of 
orientation and good quality in terms of the band width. However, all the 
samples in DMPC or DOPC contained an additional peak after high temperature 
incubations which was ~ 10-15% of the spectral intensity and the chemical shift 
near the main signal as shown on Fig. 3.35. This observation can be attributed to 
the so-called arginine anchoring, which was previously observed with Tat 
samples reach of arginine116. The guanidine groups of the arginines interact with 
the phosphate lipid head groups and therefore forms another population of them. 
 








Figure 3.35. Solid state 31P-NMR spectrum of DMPC with reconstituted SAP-TfmPro (p/l = 
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4.1. The antimicrobial peptide gramicidin S 
 
4.1.1. Activity against Gram-positive strains 
 
Careful analysis of the antimicrobial activity of the proline substituted GS 
analogues against Gram-positive bacteria reveals several unspecific tendencies. 
All MIC values were on the level of the wild type peptide, or 2-4 fold less for 
those peptides in which the fluorine content does not exceed two atoms. 
Trifuoromethylated peptides have further reduced activity. II-F2Pro-GS was 
even less active. Eventually, for the double trifluoromethylated peptides the 
activity was substantially reduced.  
The effect behind this observation can be considered as unspecific* 
fluorous effect. An increase of the fluorine content leads to an increase of the 
hydrophobicity of the substances, as was shown in chapter 3.5.1 by analysis of 
the RP-HPLC retention times. For GS, which is only modestly soluble in water, 
the solubility plays a significant role. Presumably, this parameter directly 
influences the ability of the peptide to reach the plasma membrane of the 
bacteria. Fluorination leads to an increase in the hydrophobicity and thus to a 
decrease in the solubility. A low rate of membrane binding for the most 
hydrophobic GS analogues was directly observed in CD experiments with lipid 
vesicles (chapter 3.5.3.), supporting this hypothesis. This effect can therefore be 
considered as kinetic. 
Furthermore, not only the fluorine content plays significant role in the 
reduction of the antibacterial activity. A comparison of the MIC values for the 
peptides 
- GS wild type, I-c-MePro-GS, II-c-MePro-GS, 
- I-TfmPro-GS, I-A(c)/B(t), and 
- II-TfmPro-GS, II-A(c)/B(t) 
leads to the conclusion that the presence of the methano-unit slightly decreases 
the activity within each row. This observation correlates with the increase in the 
hydrophobicity within these rows.  
 The logic of the kinetic effect suggests that the more soluble (the less 
hydrophobic) the GS analogue is, the higher the membrane binding rate and thus 
the higher its antimicrobial activity. However, for the leucine substituted 
peptides the effect was completely opposite. Incorporation of the enantiomeric 
D-amino acids decreased both the RP-HPLC retention time (hydrophobicity) 
and the bacterial grow inhibition significantly. 
 The effect behind such apparent controversion is the reduction of the 
membrane affinity. Indeed, incorporation of the D-residues instead of the 
                                                 
* the term “unspecific” here implies that this effect does not depend from the particular amino acid sequence and 
will be expected in any other peptide substituted with corresponding amino acids. 
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hydrophobic L-ones disrupts the amphiphilic molecular sidedness responsible 
for the membrane binding ability. For instance, it was shown that incorporation 
of charged NH3
+-groups in the proline residues did not improve the 
antimicrobial activity but even slightly decreased it117.  
The observation of two signals in the 19F-NMR spectrum of II-D,DFPhg-
GS in DMPC supports the latter conclusion. Apparently, in the corresponding 
two bans spectrum, one signal was from the membrane bound (oriented) and the 
other one was from the membrane detached (isotropic) peptide. Also, 
measurements of the hydrophilic II-Flp-GS in multilamellar DLPC vesicles 
showed a significant contribution of the isotropic peak in the corresponding 19F-
NMR spectrum, such that the anisotropic spectrum was almost completely 
obscured.  
 
4.1.2. Activity against Gram-negative strains 
 
The antimicrobial activity against the Gram-negative bacteria changes in a 
similar way as in the case of the Gram-positive strains. For the proline 
substituted GS analogues, the MIC values increase along with the fluorine 
content:  mono CF3 < double F2Pro < double CF3. 
However, for the leucine substituted GS analogues the activity was the 
highest in the case of the corresponding L,D-forms. This fact can be rationalized 
in terms of the effective peptide concentration. GS is less active against Gram-
negative strains, hence corresponding MIC values are simply higher than for the 
Gram-positive bacteria. Thus the effective concentration of the antibiotic in the 
soluble form has to be considered, rather than the nominal values stated in the 
MIC assay. An increase in the solubility of II-D,LFPhg/Phg-GS leads to an 
increase of its antimicrobial activity, despite the fact that molecule itself 
possesses a reduced affinity to membranes. 
Support for the given explanation was found in the results of an agar 
diffusion test (Table 4.1.). The diffusion of the D-forms in the LB-agar medium 
was apparently better than of the less soluble L-substituted peptides. The affinity 
to the membrane changes in the opposite direction. Eventually, unlike in the 
broth dilution test, II-D,LFPhg-GS showed the highest activity against Gram-
positive strains, because better diffusion was required in this case. In contrast, 
when the diffusion was not that important, II-L,LFPhg-GS was the most active. 
 










wild type GS 9 13 7 3 
II-FPhg-GS 
L,L 5 7 3 1 
L,D 9 8 1 0.5 
L,D 5 3 1 0.5 
Table 4.1. Results of an agar diffusion test for the wild type GS and II-FPhg-GS. 
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 Also, for the proline substituted analogues the critical balance between 
solubility and membrane affinity led to a better activity of the flp/Flp containing 
peptides in comparison to the others.  
 
4.1.3 Hemolytic activity 
 
An increase of the hemolysis with increasing hydrophobicity of the GS 
analogues was expected40. In this work it was shown that, in contrast to the 
antimicrobial activity, the solubility did not affect the results of the hemolytic 
tests measured by the given protocol. Any increase in the hydrophobicity 
directly increased the hemolytic activity (Fig. 4.1.). However, a closer look 
revealed secondary effects. 
In the broth dilution tests (MIC), the activity values seen for c- and t-
TfmMePro substituted GS were practically the same. The RP-HPLC retention 
times were identical. But in the hemolysis test the corresponding c-TfmMePro 
substituted peptides were less active than the t-TfmMePro containing analogues. 
The observed higher hemolysis of peptides containing t-TfmMePro, t-F2MePro 
and flp than of peptides containing the corresponding closest analogues (c-
TfmMePro, c-MePro, Flp, respectively) can be related to a tendency found in 
the CD measurements. Namely, the difference between the band ratios 
[θ]223/[θ]206 in the two mediums (PB and lipid vesicles; water and TFE) was the 
smallest for these peptides, suggesting a rigidification of the secondary structure 
as well as a pre-organization of the structure in water compared to the situation 




Figure 4.1. Interpretation of the hemolytic activity of the proline substituted GS analogues.
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 In the case of the leucine substituted peptides both the decrease in 
hydrophobicity and the secondary structure distortion lead to a significant 
decrease in hemolysis with each incorporated D-amino acid instead of an L-
one118. 
The fact that the hemolytic activity of II-L,LFPhg-GS was higher than for 
the wild type peptide can not be explaned in terms of hydrophobicity, effective 
concentration or secondary structure pre-organization. Furthermore, the 
hemolysis increased stepwise in the row wild type GS < I-LFPhg-GS < II-
L,LFPhg-GS, despite the fact, that the antimicrobial activity as well as the 
hydrophobicity (hence, the membrane affinity) was reduced. The explanation of 
this phenomenon requires consideration of other parameters, such as a specific 
propensity, observed by solid state 19F-NMR in terms of “re-alignment”. 
 
4.1.4. Understanding the specific oligomerization of gramicidin S 
 
 The binding of peptides to lipid bilayers can be described by eq. 337: 
∆Gb = ∆Ge + ∆Gh + ∆Gn + ∆Gc + ∆Gl (equation 3) 
 
where the free energies correspond to: b – binding of the peptide to the 
membrane, e – electrostatic interaction with the membrane, h – contribution of 
the hydrophobic effect, n – interaction of the non-polar peptide side chains with 
the lipid hydrophobic core, c – conformational changes in the peptide upon 
binding, l – bilayer deformation caused by peptide binding. The major 
contributions in the total free energy for gramicidin S are believed to be 
electrostatic (∆Ge), hydrophobic (∆Gh) and non-polar (∆Gn). 
In the corresponding antimicrobial activity tests hydrophobicity indeed 
pdirectly reflected on the values obtained. In the case of hemolysis, 
conformational effects played an additional role. One can presume that the 
contribution of conformational changes (∆Gc) becomes significant for binding to 
non-charged eukaryotic membranes. However, the conformational changes upon 
membrane binding in the cyclic rigid GS structure are rather small, because the 
rigid cyclic structure is maintained in general in both, aqueous solution and lipid 
vesicles. Also, in the case of II-L,LFPhg/Phg-GS, there was no stabilization or 
rigidification of the secondary structure observed in the CD correlations, but the 
hemolysis was still higher. This leads to the conclusion that in hemolysis a 
specific oligomerization of the GS molecules plays additional important role. 
Oligomerization has been previously attributed to the re-alignment of 
LGS in model membranes, as observed by solid state 19F-NMR, based on the 
fact that the re-alignment was concentration dependent. In this work, an 
additional observation was made to support this explanation. Namely, the 
presence of II-L,LPhg-GS in the II-B(t)-GS samples caused an increase in the re-
aligned population of the observed peptide (II-B(t)-GS). Apparently, L-
FPhg/Phg residues in the leucine position provide an additional motif for 
oligomerization, which is, however, not yet understood. Immersion of the II-
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L,LPhg-GS molecules into the lipid bilayer under conditions of the re-alignment 
(temperature close to the lipid phase transition, sufficiently high concentration) 
is apparently promoted by formation of oligomeric structures. Other GS 
molecules, such as II-B(t)-GS, can be incorporated into these structures to form 
mixed membrane bound oligomers. 
The results obtained for c- and t-TfmMePro substituted GS peptides can 
provide significant insights into the factors important for oligomerization in the 
membrane immersed/re-aligned state. In solid state NMR measurements, c- and 
t-TfmMePro substituted structures showed different re-alignment propensities. 
Namely, in the 19F-NMR temperature series in DLPC at p/l = 1/40, the re-
orientation range was 13° (complete within 4°) and 4°C (never complete) for II-
B(t)-GS and II-A(c)-GS, respectively. Correlation of the re-alignment in 19F-
NMR with the 31P-NMR upfield shift provided an indirect way to observate the 
peptide re-alignment by sensing the lipid head groups. In the 31P-NMR 
temperature series, II-A(c)-GS showed a “dimple” that was less deep than for II-
B(t)-GS (Fig. 4.2), in agreement with the 19F-NMR data. Thus, the specific re-
alignment is sensitive to the secondary structure that is being distorted/sustained 
by the conformationally restricted amino acids, as observed in CD. The 
hemolysis values were also higher for the t-TfmMePro substituted peptide. 
 



















Figure 4.2. Temperature dependence of the main chemical shift in 31P-NMR spectra of DLPC 
samples with II-A(c)-GS and II-B(t)-GS at p/l = 1/40. 
 
 For the leucine substituted peptides, the re-alignment propensity 
correlated with the hemolysis. Both increased in the row: wild type GS < I-
LFPhg-GS < II-L,LFPhg-GS.  
Previously, the formation of pores for mono- and divalent cations by 
gramicidin S was observed in (18:0/18:1)PG (POPG)119. Discrete conductive 
events in DPhPC/DPhPG membranes were detected after GS addition (at 
relatively high concentrations). It was also shown that GS caused membrane 
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depolarization in E. coli cells already at sub-MIC concentrations120. Later the 
electrophysiological measurements were repeated in DPhPC/DPhPG bilayers as 
well as in a few other long-chains lipids121. These measurements showed an 
absence of regular pores, such as formed by gramicidin A or alamethicin. Rather 
unspecific conductive events were observed only at high concentrations of GS. 
The discrepancy in the literature concerning GS pore formation can thus 
be explained by the wrong membrane model used for the electrophysiological 
measurements. Namely, the lipid composition should resemble the composition 
of eukaryotic cells more closely.  
The ability of GS to form putative pore is apparently much relevant for 
the leakage/lysis of eukaryotic blood cells than for the antibacterial activity. In 
each case, an increase in the re-alignment propensity correlated with an increase 
in hemolysis induced by the given peptide. The relevance of the re-alignment for 
the activity against eukaryotic cells is also supported by the facts that the re-
alignment was observed in phosphatidylcholines, and the population of the re-
aligned peptide was increased by the presence of cholesterol, which is 
characteristic for animal cells.  
 
In summary, the antimicrobial activity of the different GS analogues was 
shown to be sensitive unspecifically to (1) amphipathicity, and (2) the total 
hydrophobicity of the molecules. Introduction of D-amino acids in the leucine 
position led to a decrease of the membrane binding potency by distortion of the 
amphipathic sidedness. An increase in the hydrophobicity upon increase the 
fluorine content (fluorous effect) in the proline position lead to a decrease in the 
solubility of the peptides, and thus to a decrease in the found antibacterial 
activity. 
In contrast, the hemolytic activity did not depend on the solubility of the 
peptides, but rather (1) increased with increasing total hydrophobicity. Also, 
hemolysis (2) increases with the propensity of the peptide to oliomerize in lipid 
bilayers. The latter effect was reflected in solid state NMR measurements in 
terms of the peptide re-alignment. The oligomerization (1) is sensitive to 
distortions in the secondary structure, and (2) can be promoted by specific 
oligomerization motifs. 
 
4.1.5. Spectral populations with low molecular mobility 
 
 The basic solid state NMR parameters of the CF3-containing amino acids 
were estimated from the 19F-NMR spectra of the corresponding double 
substituted peptides in the form of lyophylized powder. Visual inspection 
(assuming symmetric tenzors) of the spectra at two different field strengths 
showed good agreement of the values obtained with the literature data for other 
CF3-containing amino acids
122. Remarkably, the chemical shift anisotropy 
(CSA) values were closer to those of aliphatic trifluormethylated amino acids 
(such as TfmBpg, 52-55 ppm) and not aromatic (such as TfmPhg, 34-39 ppm). 
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In TfmMePro, the CF3-group is attached to the cyclopropane ring, which 
possesses a partial aromatic character. However, the corresponding CSA widths 
were only slightly reduced. 
 
Peptide 19F-NMR frequency 
470.6 MHz 282.4 MHz 
CSA, ppm ∆0, kHz CSA, ppm ∆0, kHz 
II-A(c)-GS 51 16 50 16 
II-B(t)-GS 52 16 51 16 
II-TfmPro-GS 53 15 55 17 
Table 4.2. Chemical shift anisotropy (CSA) and maximal dipolar splitting (∆0) of CF3 
containing peptides (lyophilized powders; 25°C). 
 
 All measured ∆0 values were in good agreement with the theoretical 0
3CF
∆ = 
15.8 kHz. Thus, the values of the splittings given in Tables 3.7. and 3.8. can be 
interpreted in terms of the orientation angles of the CF3-group (θ) relative to the 
membrane normal, and the parameter of the molecular wobbling (Smol). 
The wobbling should narrow down the 19F-NMR spectra. For instance, the 
CSA tensor width for II-B(t)-GS in DLPC was 18 ppm at +20°C (fluid bilayers) 
and 45 ppm at -20°C (frozen bilayers), which correspond to molecular wobbling 
Smol parameters of 0.37 and 0.82, respectively. For II-
L,LFPhg-GS in fluid 
DMPC, Smol was reported
47 to be 0.34±0.05. This is in good agreement with the 
data obtained here for the proline substituted GS analogues. 
 A high molecular mobility for the GS analogues can be seen already from 
the fact that the 19F-NMR spectra contained only one triplet in all three 
characteristic situations: in the gel phase, in the fluid lipids, and in the region 
around the lipid phase transition. This was seen regardless whether amino acids 
containing one or two CF3-groups were introduced in the molecule. Remarkably, 
a significant degree of wobbling was observed even when the lipid was frozen. 
The corresponding Smol parameter was in the range 0.7 ÷ 0.8. 
In the “second re-aligned” state, which appears upon heating right after 
the frozen state, one of the splittings of the t-TfmMePro substituted peptides was 
+12-13 kHz. This value corresponds to Smol = 0.75-0.81, as in the previous 
frozen state. Thus, hysteresis in the temperature series can be explained by a 
delayed transition of the peptide from the state with reduced mobility to the state 
with higher mobility. 
 The “second re-aligned” state characterized by the two low mobile 
components was already observed in the lamellar ordered state of DMPC at 
higher (p/l = 1/20) peptide concentration, or in the presence of cholesterol as 
shown in Fig. 3.19. (solid squares). In both cases the components with low 
mobility give only a minor contribution to the total spectra. The components 
with low mobility can represent either a pure peptidic aggregate, or the lipid 
state which governs the mobility of the accumulated peptide molecules, or the 
lipid phase modulations induced by presence of the peptide. The latter can not 
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be followed by 31P-NMR so easily, because the normal lipid phase at such p/l 
ratios still prevails.  
 The effect of gramicidin S on the thermotropic phase behavior of DMPC 
was previously investigated123,124. It was shown that in the presence of 
gramicidin S at p/l > 1/100, the pre-transition Lβ – Pβ was eliminated. At higher 
peptide content (p/l = 1/25 and more) the main phase transition was slightly 
shifted towards low temperatures and a broad post-transition appeared. In 
phosphatidylethanolamine vesicles, gramicicin S caused the formation of non-
lamellar phases. 
Thus the presence of an additional lamellar phase of DMPC induced by 
the presence of GS can be assumed. In this phase the peptide possesses a lower 
mobility and two similar populations which most likely correspond to the 
surface-aligned and the re-aligned states of the same population. In the normal 
(highly mobile) state in DMPC, the re-aligned population was remarkably lower. 
The additional phase can be responsible for the formation of pores, such that one 
population (surface-aligned) is responsible for sustaining the phase, and the 
second one (re-aligned) for the non-specific pores in this phase. As was 
concluded in the previous chapter, this mechanism can be most likely 
responsible for the hemolytic activity. First, because zwitterionic PC is a model 
for uncharged eukaryotic membranes. Second, because of the correlation 
between specific oligomerization and hemolytic activity as discussed above. 
However, the low mobility state of the peptide might correspond to a completely 
alternative mechanism which could be responsible for the antibacterial activity 
as well. 
 
4.2. Cell penetrating peptide SAP 
 
4.2.1. Conformation in solution 
 
The cell penetrating proline-rich peptide SAP ([VRLPPP]3)was used as a 
model to investigate the conformational influence of different proline analogues. 
Incorporation of c-TfmMePro in position 11 of SAP showed a significant 
stabilization of the PPII structure92. In this work, the first systematic study of 
this phenomenon was presented. Remarkably, the conformational effect was 
induced by a single substitution in the whole sequence of 18 amino acids. 
The formation of an amphipathic PPII helix from the SAP sequence is 
accompained by an increase in the hydrophobic moment, and therefore leads to 
aggregation. In SAP, the proline in position 11 is located on the hydrophilic 
(arginine) face of the formed polyproline II helix. This reduces the influence of 
the hydrophobicity substituted amino acids on aggregation. Both, c- and t-
TfmMePro substitution changed the total hydrophobicity in the same way in 
gramicidin S, in contrast, the peptide pairs SAP-c-MePro – SAP-t-MePro and 
SAP-A(c) – SAP-B(t) (but not in SAP-c-F2MePro – SAP-t-F2MePro) were 
characterized by a visible differences of the RP-HPLC retention times (see 
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Table 7.2.). Namely, the peptides with the cis-methano amino acids possessed 
higher retention times than the corresponding trans-methano substituted 
analogues. This fact was already an indication that the hydrophobic moment was 
higher in the cis-methano case due to conformational changes. 
The character of the changes was then monitored by the CD 
measurements. At both tested concentrations, the trans-methano containing 
amino acids showed a significant disruption of the PPII structure and 
domination of the random coil. Even at a concentration of ~5 mM, which is 
considered to be two orders of magnitude higher than the aggregation 
concentration (50 µM)45, the disrupting effect remained.  
The PPII destabilization in the SAP analogues can be explained based on 
the following observations. In gramicidin S, where proline is enclosed in the 
type II´ β-turn, t-TfmMePro and t-F2MePro caused a remarkable ridificication of 
the peptide secondary structure, whereas c-TfmMePro and c-MePro did not. The 
high stabilization of the turn showed by the trans-methano amino acids in GS 
can be also expected for the other peptide structures. In SAP, proline-11 is 
located in the central tri-proline motif. If one amino acid forms a kink in this 
position, the whole structure loses the ability to form a stable long PPII helix. 
Thus all three trans-methano amino acids disrupt the PPII helix by forming a 
regular kink, which is most likely to be of a β-turn type, such that the whole 




































All three cis-methano amino acids stabilized the PPII helix, as could be 
judged from the CD spectra. Both c-MePro and c-TfmMePro showed 
stabilization on a very similar level, such that the elipticity [θ]227 reached the 
value reported for a pure PPII helix115. Incorporation of two fluorine atoms in 
the cis-methano unit (c-F2MePro) diminished the stabilization. The latter effect 
can be attributed to (1) either a high electron withdrawing impact of the two 
fluorine atoms, or (2) additional steric effects of the endo-fluorine atom, which 
repels the carboxyl group of the amino acid and thereby distorts the pyrrolidine 
ring geometry needed for the stabilization. 
In contrast to the methanoprolines, other amino acids used in this study 
(TfmPro, Flp, flp) did not show any significant influence on the conformation of 
SAP. The level of change they induced upon incorporation in position 11 was 
rather marginal. 
Stereoelectronic effects were expected to dominate the PPII helix 
stabilization phenomenon. Substituents in both 4- and 5-positions of the proline 
ring are known to significantly affect the proline secondary structure 
preferences. A substitutient in position 4 shifts the proline puckering 
equilibrium. Two puckers have different cis/trans populations and different 
isomerization rates67. A substitutient in proline position 5 affects the amide bond 
izomerization directly125,126. However, 4,5-methanoproline can not be considered 
just as a combination of the 4- and 5-substitutients.  
The strong effect coming just from the configuration of the methano unit 
was surprising. From a steric perspective, the pyrrolidine ring in 4,5-
methanoprolines is rather flat, such that the cyclopropane ring sticks either up or 
down in the corresponding amino acids. Thus, the difference of the φ,ψ angles in 
c- and t-MePro formed peptides should be small. Likewise, the peptide bond 
(angle ω) should experience a similar electronic influence from the 
configuration of methano unit. The collected results showed that these 
expectations were completely wrong. First of all, the methano unit configuration 
has a crucial influence at least on the cis/trans peptide bond equilibrium. In 
comparison with proline (Ktrans/cis = 4.6
*), c-MePro possesses an increased trans 
population (5.8*). The abundance of the trans-amide bond is believed to be 
crucial for the PPII folding, because in the PPII helix all peptide bonds must be 
trans. An increase in the trans-amide bond population would explain the 
stabilization effect. But surprisingly, t-MePro possesses an even higher trans-
peptide bond population (10.6*), even though in SAP this amino acid showed the 
highest disruption of the PPII conformation. 
Following the systematic analysis of the conformational effects, the 
initially observed effect of the PPII helix stabilization by c-TfmMePro was 
attributed to the cis- configuration of the methano-unit. The CF3-group was per 
se not so important. Moreover, in this work configuration of the methano-unit 
was shown to trigger the SAP secondary structure, such that in the case of the 
                                                 
* the ratios were measured in D2O for corresponding Ac-Xaa-OMe derivatives. 
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trans-amino acids PPII helices were disrupted and the random coil dominated. 
The molecular origins of these effects are still not clear and will require further 
elaboration. 
 
4.2.2. Behavior of SAP in lipids 
 
 The configuration of the methano-unit was shown to have the strongest 
effect on conformation, since SAP-c-MePro adopts pure PPII helix in solution, 
whereas SAP-t-MePro is characterized by an apparently completely disordered 
secondary structure. A CF3-group in the methano-unit gave only a small effect. 




Figure 4.3. Conformations of SAP in solution and upon binding to a lipid membrane (left). 
PPII helix of SAP (rignt). Non-polar part of the peptide is shown as white and polar – in 
black. 
 
The two peptides SAP-A(c) and SAP-B(t), showed presence of three 
(+10, +3.5, -4.5 kHz) and one (+9 kHz) triplets in oriented lipid samples, 
respectively. Similar values from the same conformational and orientational 
states were expected for the two amino acids c/t-TfmMePro, due to the fact that 
in the corresponding GS analogues they were the same. The large triplet (9-10 
kHz) was therefore attributed to the same peptide state in the spectra of both 
SAP-A(c) and SAP-B(t). The remaining two triplets in the spectra of SAP-A(c) 
must correspond to another conformational state of the peptide. The 
simultaneous disappearance of those two small splittings detected for the SAP-
A(c) peptide in the mixture with SAP-3E supports this conclusion. The SAP-
































































wild type peptide. There, two different triplets were observed in the immobilized 
state, similar to the case of SAP-A(c). 
The large splitting (10-9 kHz) most likely corresponds to an extended β-
conformation of the peptide, lying on the surface of the lipid bilayer. The 
peptide binds from the random coil in solution directly to the membrane surface 
and remains there (“projected”) as an extended β-structure (Fig. 4.3.). A direct 
proof for the extended β-conformation was taken from CD measurements of 
wild type SAP in lipids, where the total content of β-conformations increased 
upon heating and reached a maximum at ~40°C (in DMPC:DMPG 3:1 mixture, 
p/l = 1/200).  
The two small remaining triplets (+3.5 and -4.5 kHz) in the spectra of 
SAP-A(c) in lipids are apparently coming from the regular PPII helix, which is 
formed when SAP binds to the lipid surface, but with two different orientations 
of the PPII helix. Remarkably, in solution the PPII helix was practically the only 
form of this peptide (as judged from the corresponding elipticity values). In lipid 
bilayers, the content of the PPII conformation becomes reduced when compared 
to the situation in solution. The fact that heating (~50°C) was required in order 
to achieve full binding of the peptide to the lipid bilayers can explain this 
observation. Presumably, the heating leads to denaturation of the PPII helix, and 
the random coil peptide can bind better, such that the excess of the extended β-
form is eventually created. 
 
4.3. Labeling the proline position: general remarks 
 
4.3.1. Extrapolation of the data obtained for fluorine-substituted peptides to 
wild type peptides 
 
 It was clearly shown in the course of this work that substitution of proline 
with only one analogous amino acid in a peptide sequence is not enough to draw 
correct biophysical conclusions concerning the conformation and function, the 
mode of action etc. Instead, different proline analogues should be compared. 
 In investigations of antimicrobial peptides, common logic suggests that 
the microbiological function should be evaluated for the substituted peptides 
before carrying out any biophysical investigations. If the corresponding 
activities of a substituted peptide are significantly different from those of the 
wild type, the results of further biophysical explorations should not be judged as 
reliable. When the substitution alters the antimicrobial activity, there is no 
reason to perform any further investigation, because their relevance is very low. 
 Many observations in this work can find simple physico-chemical 
explanations. The biological activity of a peptide can be substantially lowered, 
but the behavior in solid state 19F-NMR can still be representative and lead to 
correct conclusions about the wild type peptide. The effects behind the 
differences in antimicrobial activities can not be related to the parameters 
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observed by solid state 19F-NMR, such as orientation, mobility, oligomerization 
state in lipid bilayers. 
For instance, a double substitution with t-TfmMePro in GS (II-B(t)-GS) 
leads to a substantial decrease in the antimicrobial activity. After the systematic 
studies using different amino acids, this effect was explained by an increased 
hydrophobicity of the substance. The decreased activity was attributed to either 
a low rate of reaching the bacterial membranes or by a low effective 
concentration in solution due to the lowered solubility. These effects can be 
considered as kinetic. In contrast, the preparation of solid state NMR samples 
implies a reconstitution of the peptide in the lipid before any further 
manipulations. Thus, kinetic effects do not play any role in the latter studies.  
Sometimes the above mentioned “common logic” can be even misleading. 
For instance, the MIC values for II-L,LFPhg-GS were closer to the corresponding 
values of the wild type than in the case of II-B(t)-GS. The HC50 values were 
decreased for both fluorine-labeled peptides to the same extent. However, 
careful exploration showed that the proline substitution was more representative 
for making conclusions on the wild type GS behavior in lipids. It turned out that 
the leucine substitution in this case created an additional motif for peptide 
oligomerization, whereas the proline substitution did not. 
 
Substitution of proline with fluorine-containing amino acids for solid state 
19F-NMR structure analysis should be planned carefully, taking into account the 
inevitable changes in hydrophobicity and conformation. Different 19F-NMR 
reporter groups also offer different opportunities for observation. These 





 Substitution of proline with 4-fluorprolines leads to a reduction of the 
hydrophobicity. This can affect the binding of the substituted amphipathic 
peptides to lipid bilayers. For instance, the most hydrophilic proline substituted 
GS II-Flp-GS, reconstituted in multilamellar DLPC vesicles (MLVs), showed a 
significant contribution of an isotropic signal in the 19F-NMR spectra. The 
isotropic signal dominated the spectra of both II-Flp-GS and II-flp-GS in the gel 
phase MLVs. This fact was attributed to a partial detachment of the peptide from 
the lipid. It was observed only for Flp/flp and not for any other proline 
substitution in GS. 
The use of these amino acids can also lead to conformational changes. It 
is known that flp prefers an endo-puckered conformation, such that the amide 
bond isomerization constant Ktrans/cis is lowered and the energy barrier between 
the trans- and cis-peptide bonds is reduced. In contrast, Flp prefers an exo-
pucker, hence the Ktrans/cis and the trans/cis barrier is higher than for proline. An 
overwhelming number of studies was done on these amino acids concerning the 
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stabilization of the collagen triple helix in collagen mimicking and other 
peptides67,127,128,129. However, it is still difficult to predict the conformational 
effects on other peptide sequences using the existing literature data. The 
corresponding effect will significantly depend on the number of substituted 
prolines and an intrinsic rigidity of the substituted segment in the initial 
structure. 
For example, in gramicidin S, double flp substitution (II-flp-GS) leads to a 
remarkable rigidification of the peptide conformation. In SAP, a single proline 
substitution with Flp/flp did not show any appreciable effect on the PPII helix – 
random coil equilibrium. 
For solid state 19F-NMR, the only parameter which can be monitored is 
the chemical shift anisotropy. The referencing problem for correct interpretation 
of this parameter still exists. In the temperature series, where the spectra were 
referenced to one another, the chemical shift was plotted against the temperature 
in order to follow the different alignment states of gramicidin S. The chemical 
shift difference between the two (aligned and re-aligned) states of GS was ~3 
ppm for II-flp-GS and ~8 ppm for II-Flp-GS. In contrast, the corresponding 
difference for II-B(t)-GS was 28 ppm. Apparently, the CSA is reduced for the 
flp/Flp peptides. Presumably, the proline puckering is still happening in the 
corresponding peptides. The side chain wobbling narrows down the spectra. The 
presence of wobbling makes a conversion of the CSA into orientation/wobbling 
parameters of the peptide a complicated task. Therefore, the Flp/flp substitution 
should be used only for qualitative characterization of different peptide states in 
the same sample.  
An advantage of these amino acids is the fact that they are easily available 




 The two amino acids, c/t-TfmMePro, require complicated chemical 
synthesis. However, both amino acids were fairly compatible with the SPPS 
protocol. When introduced into peptides, they increase the hydrophobicity 
substantially. The influence of the latter effect on the activity values was 
discussed above. 
 In both studied peptides, the amino acids induced significant changes in 
the secondary structures. The corresponding conformational effects have been 
described here the first time. It was possible to compare the effect of the 
different substitutions and extrapolate to the properties of the wild type peptide. 
Comparison of the  RP-HPLC retention times, biological activities, solid state 
19F-NMR line shapes, etc., for the c- and t-TfmMePro substituted peptide pairs 
was most fruitful in the course of this work. 
 In the solid state 19F-NMR investigations the peptides substituted with 
these two amino acids gave the most representative spectral line shapes. The 
CF3-group triplets were well resolved, and the resolution enabled to discriminate 
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between different peptide states in one spectrum, and the relatively short spectra 
collection times were sufficient for collecting high-quality spectra. These 
features were essential for making some conclusions, concerning the low 
mobility state in GS, concerning two orientational states of the SAP PPII helix, 
etc. The attachment of a CF3-group to the restricted bicyclic skeleton makes the 
values of the CSA and dipolar coupling easily convertible into peptide 
orientation/wobbling parameters. 
 The use of only one amino acid for the substitution, either c- or t-
TfmMePro, will give less representative results, because the conformational 
changes are supposed to be significant. On the other hand, a combination of both 
amino acids for proline substitution, combined with further solid state 19F-NMR 




 The amino acid TfmPro is not commercially available, but the synthesis is 
relatively simple, and the amino acid is well compatible with the SPPS protocol. 
An increase in the hydrophobicity upon Pro to TfmPro substitution should be 
expected. 
 However, in both of the studied peptides no substantial conformational 
changes were noticed. Thus, TfmPro can be considered a non-perturbing 
substitutient concerning conformational changes. 
 In solid state 19F-NMR both parameters, CSA and dipolar coupling, can 
be measured and converted into the corresponding structural 
orientation/wobbling parameters. The absence of any significant spectral 
narrowing, as was observed for Flp/flp, indirectly proves that the anchoring of 
the pyrrolidine ring was indeed achieved. From a practical perspective, the 
spectral resolution was not as good as in the c/t-TfmMePro case. Therefore, not 
all alignment states that were clearly distinguished using c/t-TfmMePro, were 
observed in the spectra of TfmPro substituted peptides. 
 Marginal conformational changes and the presence of a CF3-label make 
this amino acid a good choice for solid state 19F-NMR structural studies of 
peptides. 
 
4.3.5. F2MePro and F2Pro 
 
 F2Pro is very easy to synthesize and it is fully compatible with the Fmoc 
SPPS. Conformational changes induced by this amino acid are rather small. The 
hydrophobicity changed not much from a single substitution. In solid state 19F-
NMR, the use of the corresponding peptides can only be affordable in the fluid 
lipid state and not in the gel phase. 
 F2MePro is not compatible with SPPS. Incorporation of this amino acid 
into peptides requires prior synthesis of the corresponding dipeptides. There is 
also no guarantee that the synthesis will yield significant amounts of the c-
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F2MePro form. Use of the pair c/t-F2MePro imposes similar advantages as use of 
the c/t-TfmMePro pair. Moreover, F2MePro increases the hydrophobicity less 
than any CF3-containing amino acid. In solid state 
19F-NMR, the use of  
F2MePro makes it possible to follow different peptide states even in the gel lipid 
phase. 
 The characteristic shape of the 19F-NMR peptide spectra in fluid lipids 
were shown to be defined by two parameters: (1) chemical shift difference 
between the two inequivalent fluorines, (2) dipolar coupling. The latter can be 
used for conversion into the orientation/wobbling parameters. However, such 
CSA and ∆0 simulations still have to be done. 
 The use of the pair c/t-F2MePro as a strategy for proline substitution 
should be preferred in cases where the hydrophobicity plays a substantial role.  
 
In summary, the following strategies can be applied to substitute the 
proline substitution in peptides for 19F-NMR structural investigations: 
(1) Combination of c- and t-TfmMePro can be considered as the best option, 
as the effect of the substitution can be discriminated from the original 
peptide properties, 
(2) The use of TfmPro should be considered as a compromise, 
(3) A combination of c- and t-F2MePro is a good alternative to (1), if the 



























 This work has examined the incorporation of different proline analogues 
into peptides and their sutability for 19F-NMR and biophysical studies. The 
amino acids were incorporated into two peptide sequences, and systematic 
investigations were carried out in order to reveal any induced conformational 
changes in the two secondary structures, namelly the relevant β-turn and 
polyproline type-II helix. It was shown that the β-turn type II` is stabilized by 
several amino acids, some of them containing a trans-4,5-methano unit. The 
previously observed stabilization of the PPII structure in SAP was attributed to 
the cis-configuration of the 4,5-methano unit. Moreover, the trans-4,5-methano 
prolines substantially disrupted this secondary structure.  
 In gramicidin S, the effects of different proline substitutions were 
systematically investigated. It was shown that the antibacterial activity was 
affected rather unspecifically by changing the hydrophobicity and 
amphipathicity of the peptide molecule. An increase in the hydrophobicity, first 
of all by increasing the fluorine content, substantially decreased the activity. 
This effect was explained by a reduced rate of binding of the peptide to the cell 
membranes. Additional studies of the leucine substituted peptides showed that a 
decrase in the hydrophobicity decreases the activity by lowering the membrane 
affinity. Thus, the native GS structure is well optimized in terms of balancing 
these two opposing effects. Remarkably, any conformational changes did not 
affect the antibacterial activity. But an additional contribution of the 
conformational effect was found for the hemolytic activity. This observation 
was rationalized in turms of a mechanism in which oligomerization of the 
peptide molecules in the lipid membranes was considered. This oligomerization 
was monitored by solid state 19F-NMR in terms of the previously described GS 
re-alignment. An increased propensity for the re-alignment provided the only 
valuable explanation of the observed increase in the hemolytic activity in several 
cases. In fact, the antibacterial and the hemolytic activity seem to involve 
different mechanisms. 
 The use of fluorine containing amino acids as labels for solid state 19F-
NMR studies wasdemonstrated and discussed. Proline in peptides is sensitive to 
substitutions, hence the use of certain analogues was recommended in order to 
extract information on the effect of the substitution and on the properties of the 
wild type peptide. Based on this work, the number of the amino acids needed for 
investigations of other peptides can now be well adjusted and the effort reduced. 
 A novel amino acid, difluoro-4,5-methanoproline, was synthesized. Being 
N-deprotected, this structure was intrinsically unstable. The mechanism of its 
decomposition was elucidated. Finally, the amino acid was incorporated into 
peptides using a dipeptide strategy. Sodium chlorodifluoroacetate was used for 
the first time for difluorocyclopropanation of protected enamines. The 
preferential formation of the trans-methano isomer and formation of an 




In dieser Arbeit wurde der Einbau verschiedener Prolin Analoga in 
Peptide, sowie deren Eignung für 19F-NMR und biophysikalische Studien 
untersucht. Die Aminosäuren wurden in zwei verschiedene Peptidsequenzen 
eingebracht, die daraufhin systematisch auf jegliche induzierte Änderung der 
beiden Sekundärstrukturen, genauer der β-Schleife und der Polyprolin Typ II 
Helix, untersucht wurden. Es wurde gezeigt, dass einige Aminosäuren, unter 
denen manche eine trans-4,5-methano Einheit enthalten, die β-Schleife Typ II 
stabilisieren. Die bereits zuvor beobachtete Stabilisierung der PPII Struktur in 
SAP wurde auf die cis-Konfiguration der 4,5-methano Einheit zurückgeführt. 
Des Weiteren störten die trans-4,5-methano Proline diese Sekundärstruktur 
erheblich. 
In Gramicidin S wurden die Effekte der verschiedenen Prolin-
Substitutionen systematisch untersucht. Es wurde gezeigt, dass die 
antimikrobielle Aktivität eher unspezifisch durch Änderung der Hydrophobizität 
und Amphiphilie des Peptides beeinflusst wurde. Eine Erhöhung der 
Hydrophobizität, in erster Linie durch einen erhöhten Fluor-Gehalt, minderte die 
Aktivität erheblich. Dieser Effekt wurde durch eine verringerte Bindungsrate des 
Peptids an die Zellwand erklärt. Zusätzliche Studien Leucin substituierter 
Peptide zeigten, dass eine Herabsenkung der Hydrophobizität die Aktivität 
durch eine verringerte Membranaffinität senkte. Demnach ist die native GS 
Struktur in Hinsicht auf die Balance zwischen diesen beiden sich 
entgegenstehenden Effekten gut optimiert. Bemerkenswerterweise beeinflusste 
keinerlei konformationelle Änderung die Aktivität. Jedoch wurde ein 
zusätzlicher Beitrag des konformationellen Effekts für die hämolytische 
Aktivität gefunden. Diese Beobachtung wurde durch einen Mechanismus, bei 
welchem die Oligomerisierung der Peptid Moleküle in der Lipidmembran 
angenommen wurde, erklärt. Diese Oligomerisierung wurde, im Zusammenhang 
mit der zuvor beschriebenen GS Umorientierung, mittels 19F-NMR beobachtet. 
Eine erhöhte Tendenz zur Umorientierung lieferte die einzige sinnvolle 
Erklärung der beobachteten Erhöhung der hämolytischen Aktivität in einigen 
Fällen. In der Tat scheinen die antibakterielle und die hämolytische Aktivität mit 
verschiedenen Mechanismen einherzugehen. 
Die Verwendung Fluor-haltiger Aminosäuren als Markierungen für 
Festkörper 19F-NMR Studien wurde demonstriert und diskutiert. Prolin reagiert 
in Peptiden sehr empfindlich auf Substitutionen, daher wurde der Gebrauch 
bestimmter Analoga empfohlen um Informationen über den Effekt der 
Substitution und die Eigenschaften des Wildtyp Peptids zu erhalten. Basierend 
auf dieser Arbeit, kann die Anzahl der benötigten Aminosäuren für 
Untersuchungen angepasst und der Aufwand reduziert werden. 
Eine neue Aminosäure, Difluoro-4,5-methanoprolin, wurde synthetisiert. In 
ihrer N-entschützten Form war diese Struktur intrinsisch instabil. Der 
Mechanismus ihres Zerfalls wurde erläutert. Schließlich wurde die Aminosäure, 
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mittels einer Dipeptid Strategie, in Peptide eingebracht. 
Natriumchlorodifluoracetat wurde zum ersten Mal für 
Difluorocyclopropanierung von geschützten Enaminen verwendet. Die 
bevorzugte Bildung des trans-methano Isomers sowie die Entstehung eines 




































7. Experimental part 
 
1H-NMR spectra were recordered on Bruker Avance 400 and Bruker 
Avance DRX 500 spectrometers and referenced to TMS. 19F-NMR spectra in 
solution were recordered on Bruker Avance 300 spectrometer (282 MHz) at 
23°C and referenced to TFA solution in water (-75 ppm). δ values are given in 
points per million. IR spectra were recordered on Bruker Alpha spectrometer 
with diamond-ATR module, the values are given in cm-1 (only bands above 
1500 cm-1). Optical rotation was measured on Perkin-Elmer 241 Polarimeter at 
20°C in chloroform. MALDI-TOF spectra were recordered on Bruker Autoflex 
III Smart Beam. 
RP-HPLC was done on Jasco HPLC system using (unless other stated) 
C18 columns: 4.6 mm x 250 mm as analytical (flow rate 1.5 ml/min), 10 mm x 
250 mm as semi-preparative (6 ml/min) and 22 mm x 250 mm as preparative (20 
ml/min); solvent A: 90% water, 10% acetonitrile, solvent B: 90% acetonitrile, 
10% water; 5 mM hydrochloric acid was used as an ion-pairing agent. 
Analytical gradient from 5 to 95% of solvent B starting from 3 min ending at 18 
min (15 min), the loop size was 20 µl, the temperature 40°C. 
Tetrahydrofuran (THF), diglyme, DIPEA, and diethyl ether were freshly 
distilled under argon atmosphere from sodium/benzophenone, toluene was 
distilled from sodium. Trifluoroacetic anhydride was distilled over potassium 
carbonate. All other chemicals were of commercial grade (purchased from 
Merck, Acros, ABCR, Fisher, Iris Biotech, Biosolve) and used without further 
purification unless other stated. Compound 50 was prepared from pyroglutamic 
acid in three steps according to130,131,132. (S)-tert-butyl pyroglutamate was 
prepared according to97. 28 was prepared according to133,134 and finally reaction 
with the Ruppert-Prakash reaget was done according to85. The wild type GS was 
provided by Dr. Berditsch and O. Babii; the SAP wild type and SAP-A(c) were 
synthesized by Dr. Mykhailiuk. Lipids were bought in Avanti Polar Lipids. The 
amino acids Boc-c-MePro and HCl*t-MePro were provided by Prof. Komarov. 
 




A 250 ml three necked reactor equipped with a 
dropping funnel and a Liebig condenser was charged with 50 
(1 g, 4.4 mmol) and dry diglyme (60 ml) under argon. The 
mixture was heated to 177 °C in an oil bath, and slurry of 
sodium chlorodifluoroacetate (10.1 g, 66.4 mmol, 15 eq.) in 
diglyme (40 ml) was added under stirring through the dropping funnel within 15 
min. After the addition, the mixture was heated with stirring for 5 min, keeping 
the temperature strictly within the range of 175-178 °C over this period. Then 






filter. The solid on the filter was washed with ether, the combined filtrate and 
washings were evaporated under reduced pressure. The residue was purified by 
column chromatography (silica gel, eluent – hexane-ethyl acetate 2:1, Rf = 0.5). 
0.860 g (71% yield) of the product 51 was obtained as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) – (Boc-rotamers): 4.39 (major) and 4.17 
(minor) (m, 1H, N-CH-CO2Me), 3.99 (minor) and 3.80 (major) (m, 1H, N-CH-
CF2), 3.76 (s, 3H, CO2CH3), 2.62 (m, J = 10-11Hz, 1H, CHH), 2.34 and 2.28 
(two m, 2H, CH-CH-CHH), 1.48 (major) and 1.43 (minor) (s, 9H, (CH3)3C).
 
19F-NMR (CDCl3, 282 MHz) – (Boc-rotamers): -129.7 (major) and -130.0 
(minor) (dd, JF-F = 160 Hz, JF-H = 10 Hz, exo-F), -155.7 (minor) and -156.2 
(major) (d, JF-F = 160Hz, endo-F). IR: 2978, 1750, 1704. [α]D = 105° (c = 1.01). 
 
(1S,3S,5R)-2-(tert-butoxycarbonyl)-6,6-difluoro-2-
azabicyclo[3.1.0]hexane-3-carboxylic acid, 52. 
51 (0.5 g, 1.8 mmol) was dissolved in methanol (15 ml). 
A sodium hydroxide solution (1M in water, 7.3 ml, 4 eq.) was 
added to the solution within two minutes upon stirring. The 
solution was stirred for 6 h at room temperature, and then 
methanol was evaporated under reduced pressure (keeping the 
bath temperature below 40 °C). The residue was taken up in water (15 ml), 
extracted with diethyl ether (2 x 15 ml), and the ethereal extracts were 
discarded. The water layer was then acidified by 1 M hydrogen chloride solution 
until acidic pH (1-2) and the product was extracted with dichloromethane (4 x 
15 ml). The combined extracts were dried over magnesium sulfate, filtered and 
evaporated to give 0.433 g (91% yield) of the product as pale fluffy crystals. 
1H-NMR (CDCl3, 500 MHz) – (Boc-rotamers): 8.80 (broad s, 1H, CO2H), 
4.39 (major) and 4.24 (minor) (m, 1H, CH-CO2Me), 4.02 and 3.76 (m, 1H, N-
CH-CF2), 2.73 (m, 1H), 2.61 (major) and 2.47 (minor) (m, 1H, both CH2), 2.36 
(m, 1H, CH-CH-CH2); the assignment was accomplished using HMQC 
experiment. 19F-NMR (CDCl3) – (Boc-rotamers): -129.9 (minor) and -130.8 
(major) (dd, JF-F = 162Hz, JF-H = 12 Hz, exo-F), -155.9 (minor) and -156.3 
(major) (d, JF-F = 161 Hz, endo-F). IR: broad 3300-2500, 2981, 2935, 1747, 




To 51 (0.6 g) trifluoracetic acid-dichloromethane mixture 
(3 ml : 9 ml) was added quickly upon stirring. After 30 min 
stirring at room temperature volatilities were evaporated 
(temperature in bath < 30°C) within 5 min and acetic anhydride 
(25 ml) was added. The mixture was stirred for 12 h. Liquids 
were removed under reduced pressure (temperature ≤ 60°C), the residue was 
taken up in ethyl acetate (50 ml), washed with 1M hydrogen chloride (3 x 25ml), 










magnesium sulphate, filtered and evaporated. The crude product was purified 
via gradient silica gel chromatography (ethyl acetate – chloroform 8.5:1.5 to 5:5 
ratio) to give 41mg (9%) of the product as colorless oil. 
1H-NMR (CDCl3, 400MHz): 4.59 (d, J = 8.3Hz, 1H, N-CH-CO2Me), 3.78 
(m, 1H, N-CH-CF2), 3.69 (s, 3H, CO2CH3), 2.55-2.28 (m, 3H, CH-CH-CH2), 
2.12 (s, 3H, N-C(=O)CH3).
 19F-NMR (CDCl3): -128.3 (dm, JF-F= 159Hz, 1F), -
155.7 (d, JF-F= 159Hz, 1F). 
 
7,7-difluoro-2-aza-bicyclo[4.1.0]heptane-2-carboxylic acid tert-butyl 
ester, 55. 
The starting compound was prepared in two steps from 
valerolactame analogous to 50. The synthesis was done analogous to 
synthesis of 51.  The charged amounts were: 1.5 g (8.1 mmol) of the 
starting Boc-enamine and 12.5 g (82 mmol, 10eq.) of the salt. The 
reaction time was 35 min. The product 55 was purified by column 
chromatography (silica gel, eluent – hexane:diethyl ether 2:1, Rf = 0.5). 
Resulting compound was pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) – (Boc-rotamers): 3.78 (major) and 3.54 
(minor) (dt, J= 13, 4Hz, 1H, CF2-CH-N), 3.21 (minor) and 3.12 (major) (m, 1H), 
2.67 (minor) and 2.48 (major) (m, 1H), 1.82-1.62 (m, 3H), 1.49 (m, 2H), 1.41 (s, 
9H, CH3). 
19F-NMR (CDCl3) – (Boc-rotamers): -130.0 (minor) and -130.5 
(major) (ddd, JF-F = 163Hz, JF-H = 14, 8 Hz, exo-F), -152.3 (major) and -152.9 
(minor) (d, JF-F = 163Hz, endo-F). IR: 2976, 2940, 2870, 1699. 
 
7,7-difluoro-2-azonia-bicyclo[4.1.0]heptane trifluoroacetate, 56. 
55 (129 mg) was mixed with trifluoroacetic acid in 
dichloromethane (6 ml; 1:9 vol) for 1 h. The volatiles were 
evaporated and the product was obtained as yellow viscous liquid. 
1H-NMR (CDCl3, 400 MHz): 9.76 and 7.90 (to broad s, 2H, 
NH2), 3.46 (t, J= 9 Hz, 1H, CF2-CH-N), 3.30 (m, 1H), 3.04 (m, 1H), 
2.15 (m, 1H), 2.06 (m, 2H), 1.89-1.69 (m, 2H). 19F-NMR (CDCl3): -




Sodium hydride (60% in paraffin, 512 mg, 12.8 
mmol) was washed with dry toluene (2 x 5 ml) under argon, 
70 ml of dry toluene (70 ml) was added following by tert-
butyl pyroglutamate (2.26 g, 12.2 mmol) upon stirring. After 
30 min Boc-DPhe-ONp (4.5 g, 11.6 mmol) suspension in 
toluene (40 ml) was added quickly and the stirring was 
continued for the next 16 h. The reaction mixture was filtrated and the filtrate 



















chromatography (silica gel, eluent – hexane:ethyl acetate 3:1, Rf = 0.3) as white 
crystals. 
1H-NMR (CDCl3, 400MHz) – (rotamers): 7.32-7.17 (m, 5H, Ph), 5.78 and 
5.70 (m and broad m, 1H, CH-C(=O)-N), 5.19 and 4.99 (d and broad m, J= 
8.5Hz, 1H, NH), 4.49 (d, J= 9.3Hz, 1H, CH-CO2Bu
t), 3.16 and 3.08 (two m, 1H, 
CHH-N) and 2.90 (m, 1H, CHH-N), 2.76 (two m, 1H, CHH in Phe), 2.51 (ddd, 
J= 17.8, 9.2 and 2.1Hz, 1H, CHH in Phe), 2.24 (m, 1H, N-CH2-CHH), 2.07 (m, 
1H, N-CH2-CHH), 1.47, 1.40 and 1.31 (three s, CH3). IR: 3422, 2981, 2934, 




Was prepared analogous to 57 starting from 2.60 g (14 
mmol) of tert-butyl pyroglutamate and 4.5 g of Boc-Pro-ONp 
(13.4 mmol). 4.25 g (83%) of the product was obtained as 
white crystals after chromatography (silica gel, eluent – 
toluene:ethyl acetate 9:2, Rf = 0.4). 
1H-NMR (CDCl3, 400 MHz) – (rotamers): 5.37 (m, 1H, 
N-CH-C=O), 4.70 (m, 1H, N-CH-C=O), 3.58 (m, 1H, N-CHH), 3.44 (m, 1H, N-
CHH), 2.76-2.49 (m, 2H), 2.43-2.29 (m, 2H), 2.13-1.96 (m, 2H), 1.89 (m, 2H), 
1.47, 1.46, 1.45 and 1.38 (four s, 18H, C(CH3)3). IR: 2976, 2940, 2891, 1740, 




Was prepared according to the protocol134 starting 
from 57 (3 g). 2.20 g (76%) of the product 58 was obtained 
after chromatography (silica gel, eluent – hexane:ethyl 
acetate 4:1, Rf = 0.3). 
1H-NMR (CDCl3, 400MHz) – (rotamers): 7.33-7.15 
(m, 5H, Ph), 6.39 (m, 1H, N-CH=CH), 5.39 (d, J= 9Hz, 1H, NH), 5.02 (m, 1H, 
N-CH=CH), 4.76 (m, 1H, CH-C(=O)-N), 4.52 (dd, J= 5, 11Hz, 1H, CH-
CO2Bu
t), 3.03 (d, J= 7Hz, 2H, , CH=CH-CH2), 2.90 (m, 1H, CHH in Phe), 2.52 
(two m, 1H, CHH in Phe), 1.47 and 1.43 (two s, 18H, CH3). IR: 3307 (broad), 




Was prepared according to the protocol134  starting from 
the corresponding Pro-Pyr derivative (3 g). 2.00 g (70%) of 
the product was obtained after chromatography (silica gel, 
eluent – toluene:ethyl acetate 9:2, Rf = 0.6).
 
1H-NMR (CDCl3, 400 MHz) – (rotamers): 6.55 (m, 1H, 



















m, 1H), 3.53 (m, 1H), 3.42-3.28 (m, 1H), 2.97-2.86 (m, 1H), 2.55-2.43 (three m, 
1H), 2.18-2.05 (m, 1H), 2.05-1.91 (m, 2H), 1,86-1.74 (m, 1H),  1.39, 1.38, 1.38 
and 1.31 (four s, 18H). IR: 2971, 2926, 2870, 1746, 1698, 1660, 1625. [α]D = -





Was synthesized according to the protocol for 51. The 
charged amounts were 1 g (2.4 mmol) of 58 and 9.2 g (60.3 
mmol, 25 eq.) of the salt. The total reaction time was 40 
min. After chromatography (silica gel, eluent – hexane:ethyl 
acetate, Rf = 0.6) 400 mg (36%) of transparent glass 
fractions  was obtained out of the column from which the 
first part was 60 and the last (main) part was pure 59. The 
ratio was estimated as 2:9 after analysis of the NMR spectra of all fractions.  
1H-NMR (CDCl3, 400MHz) – two N-Boc rotamers, δ, ppm: 7.31-7.18 (m, 
5H, Ph), 5.20 (m, 1H, NH), 4.83 (q, J= 7Hz, 1H,  CH-CH2-Ph), 4.36 (dd, J= 10, 
4Hz, CH-CO2Bu
t), 4.30 (dd, J= 9, 5Hz, N-CH-CF2), 3.13 (dd, J= 14, 6Hz, 1H, 
CHH in Phe), 2.86 (dd, J= 14, 7Hz, 1H, CHH in Phe), 2.59-2.49 (m, 2H, CF2-
CH-CHH), 2.33 (m, 1H, CF2-CH-CHH), 1.47 and 1.40 (two s, 9H, CH3).
 19F-
NMR (CDCl3) – (rotamers): -127.9 (minor) and -128.7 (major) (ddd, JF-F= 
160Hz, JF-H= 15, 4Hz, exo-F), -153.9 (major) and -157.0 (minor) (d, JF-F= 





1H-NMR (CDCl3, 400MHz), δ, ppm: 7.33-7.13 (m, 
5H, Ph), 5.11 (q, J= 7Hz, 1H, CH-CH2-Ph), 4.54 (dd, J= 9, 
4Hz, 1H, CH-CO2Bu
t), 4.24 (dd, J= 5, 9Hz, 1H, N-CH-
CF2), 3.30 (dd, J= 14, 5Hz, 1H, CHH in Phe), 3.00 (dd, J= 
14, 7Hz, 1H, CHH in Phe), 2.63 (m, 2H, CF2-CH-CHH), 
2.40 (m, 2H, CF2-CH-CHH), 1.47 (s, 9H, CH3).
 19F-NMR 
(CDCl3) – (rotamers): -63.8 (s, 2F, CF2), -128.3 (ddd, JF-F= 
160Hz, JF-H= 14, 4Hz, exo-F), -153.2 (d, JF-F= 160Hz, endo-





carboxylate,  63. 
Was synthesized according to the protocol for 51. The charged amounts 



















salt. The total reaction time was 30 min. In chromatographic 
purifications (silica gel, eluent – hexane:ethyl acetate 2:1, Rf 
=  0.3) mixed fractions of 63 and 64 were collected first, 
followed by the fractions containing pure 63. The overall 
yield of isomers collected was 657 mg (58%), the ratio of 
the isomers in the initial mixture (1:5) was estimated from 
19F-NMR spectra and analytical HPLC. Pure 63 was a white solid. 
1H-NMR (CDCl3, 400 MHz, two rotamers, δ, ppm): 4.53 (m, both N-CH-
C=O of the minor isomer, both amino acid residues), 4.47 (m, N-CH-C=O 
major isomer, the F2MePro residue), 4.40 (m, N-CH-C=O, major isomer, the 
Pro residue) – 2H in total, 3.72 (m, 1H, N-CH-CF2), 3.53-3.30 (m, 2H, N-CH2), 
2.44 (m, 2H, CF2-CH-CHH), 2.24 (m, 2H, CF2-CH-CHH and N-C(=O)-CH-
CHH), 2.01 (m, 1H, N-C(=O)-CH-CHH), 1.96-1.77 (m, 2H, N-CH2-CH2), 1.39 
and 1.33 (two s, C(CH3)3). ). 
19F-NMR (CDCl3) – (rotamers): -126.7 (minor), -
127.0 (major) (ddd, JF-F = 158 Hz, JF-H = 14, 3 Hz, exo-F), -154.2 (major), -154.5 
(minor) (d, JF-F = 158 Hz, endo-F). IR: 2973, 2931, 2877, 1718, 1688, 1662. [α]D 





Was obtained after preparative RP-HPLC using water 
and methanol as solvents A and B respectively. 64 was 
collected after 63 as a mixture of 64 and 63 ~ 9:1 (estimated 
from analytical HPLC and 19F-NMR). 
1H-NMR (CDCl3, 300 MHz, two rotamers, δ, ppm): 
4.78 (m, 1H, N-CH-CO2Bu
t), 4.55 and 4.45 (two m, 1H, N-
CH-C(=O)-N), 4.19 and 3.91 (two m, 1H, N-CH-CF2), 3.60-
3.29 (m, 2H, N-CH2), 2.57 and 2.21 (two m, 2H, CH2, the F2MePro residue), 
2.32 (m, 1H, CF2-CH-CH2), 2.05 (m, 3H, CH-CH2-CHH-CH2), 1.81 (m, 1H, 
CH-CH2-CHH-CH2), 1.38, 1.35 and 1.34 (three s, 18H, two C(CH3)3). 
19F-NMR 
(CDCl3) – (rotamers): -126.0 (minor) and -126.3 (major) (dd, JF-F = 162 Hz, JF-H 
= 14 Hz, exo-F), -151.7 (major) and -151.9 (minor) (d, JF-F = 162 Hz, endo-F). 
IR: 2973, 2939, 2882, 1746, 1681. [α]D= -48° (c = 0.98). 
 
(1S,3S,5R)-6,6difluoro-2-{(2R)-2-[(9H-fluoren-9-ylmethoxy)amino]-3-
phenylpropanoyl}-2-azabicyclo[3.1.0]hexane-3-carboxylic acid, 61. 
59 (206 mg, 0.44 mmol) was dissolved in 
dichloromethane (5 ml) and trifluorocetic acid (1.5 ml) was 
added upon stirring. After 1.5 h the volatilities were removed 
under reduced pressure, the residue was additionally 
evaporated from dichloromethane (5 ml) twice and then taken 
up in 10% solution of sodium carbonate (1.2 ml) until pH 























OSu (164 mg, 0.49 mmol) in acetone (2 ml). The mixture was stirred for the 
next 27 h at room temperature and then volatilities were removed under vacuum 
(temperature in bath was ≤ 30°C), the water solution was diluted with water (50 
ml). Water layer was extracted with diethyl ether (2 x 20 ml), the water fraction 
was acidified with hydrogen chloride solution (1M) until pH was ~ 1. The water 
layer was extracted with ethyl acetate (4 x 30 ml). The ethyl acetate fractions 
were dried over sodium sulphate and concentrated under vacuum. The residue 
was lyophylized from acetinitrile-water mixture to give 193 mg (82%) of 61 as a 
white powder. 
1H-NMR (CDCl3, 400MHz) – (rotamers only the major rotamer signals 
are denoted, minor rotamer content is less than 20%): 7.76 (d, J= 7.6Hz, 2H), 
7.53 (t, J= 8Hz, 2H), 7.40 (t, J= 7Hz, 2H), 7.34-7.18 (m, 7H), 7.04 (broad s, 
CO2H), 5.80 (d, 1H, NH), 4.91 (m, 1H), 4.70-4.05 (m, 5H), 3.17 (dd, J= 5.7, 
14Hz, 1H, CHH in Phe), 2.93 (dd, J= 7.8, 14Hz, 1H, CHH in Phe), 2.64-2.48 
(m, 3H). 19F-NMR (CDCl3) – (rotamers): -128.2 (minor) and -128.8 (major) (dd, 
J= 12, 161Hz, exo-F), -153.0 (minor) and -153.4 (major) (d, J= 160Hz, endo-F). 






Was synthesized analogous to 61. 141 mg (94%) of the 
product was obtained out of 130 mg of 63 as white powder. 
1H-NMR (CDCl3, 400 MHz) – (rotamers): 7.67 (m, 
2H), 7.56-7.44 (m,2H), 7.31 (m, 2H), 7.23 (m, 2H), 7.07 
(broad s, 1H), 4.70-4.10 (m, 5H), 3.73-3.44 (m, 3H), 2.57-
1.83 (m, 7H). 19F-NMR(CDCl3) – (rotamers): -128.0 (dm, J = 
161 Hz, exo-F), -153.9 (minor) and -154.1 (major) (two d, J = 
160 Hz, endo-F). IR: 3600-2400 (broad), 2958, 2889, 1706, 1674, 1522. [α]D = -





This compound was prepared analogous to 61, starting 
from 64 (42 mg, 0.1 mmol). As the amount of the compound 
syntheized (33 mg, 67% yield) was too small for its full 
characterization, only 19F-NMR spectrum was run and the 
compound was immediately used for the peptide synthesis. 
19F-NMR (CDCl3) – (rotamers): -126.9 (minor) and -
127.4 (major) (dm, JF-F = 162 Hz, exo-F), -151.4 (major) and -151.8 (minor) (d, 

















Thionyl chloride (7 ml) was added to a stirred solution of 
28 (2.34 g, 7.5 mmol) in dry pyridine (100 ml). The mixture 
was heated up until reflux for 25 min in total. Water (25 ml) 
was carefully added in order to quench the reaction. The dark 
mixture was extracted by pyridine (100 ml) and ether (3 x 150 ml). Combined 
organic fractions were evaporated, diethyl ether (300 ml) was added and 
resulting solution was washed with hydrogen chloride (2 M, 2 x 150 ml), 
saturated sodium hydrocarbonate (150 ml), water (150 ml) and brine (150 ml), 
dried over sodium sulphate and evaporated to give 1.59 g (72%) of 66 as wine 
oil. 
1H-NMR (CDCl3, 400MHz) – (Boc-rotamers): 6.19 (td, J = 19, 2 Hz, 1H, 
CH=CCF3), 5.08 (two m, 1H, N-CH-CO2Me), 4.33 (m, 2H, N-CH2), 3.71 (two 
s, 3H, CO2CH3), 1.42 and 1.37 (two s, 9H, C(CH3)3).
 19F-NMR (CDCl3): -65.3 





A mixture of 66 (790 mg, 2.7 mmol) and palladium on 
carbon (10%, 0.5 g) in methanol (15 ml) was stirred under 
hydrogen atmosphere (1 atm) at room temperature for 21 h. 
The mixture was filtered and evaporated giving 744 mg of 67 
(94%) as colourless oil. 
1H-NMR (CDCl3, 400MHz) – (Boc-rotamers): 4.42 and 4.33 (two t, J = 8 
Hz, 1H), 3.92 and 3.84 (two t, J = 10Hz, 1H), 3.77 (s, 3H), 3.51 (t, J = 10Hz), 
2.96 (m, 1H), 2.56 (m, 1H), 2.14 (m, 1H), 1.49 and 1.43 (two s, 9H). 19F-NMR 
(CDCl3): -70.4 (d, JH-F = 8.4 Hz, CF3). IR: 2987, 2870, 1747, 1695. [α]D = -70° 
(c = 2.1). 
 
7.1.1. Procedures towards Fmoc-amino acids 
 
 Miscellaneous Fmoc-amino acids were synthesized according to Sheme 
3.7. in chapter 3.3. After the synthesis purity of the Fmoc-Xaa-OH was checked 
on analytical HPLC and the substances were launched in peptide synthesis 
without characterization. The syntheses were performed analogously, few 
procedures are described below. Fmoc-OSu was preferred for small amounts 




















67 (711 mg, 2.4 mmol) was dissolved in methanol (10 ml), sodium 
hydrohyde solution in methanol (1M, 5 ml) was added and the solution was 
stirred at room temperature for two hours. Methanol was removed under reduced 
pressure (temperature in bath ≤ 36° C), the rest was dissolved in water (20 ml) 
and extracted with diethyl ether (2 x 10 ml). The water layer was acidified by 
hydrogen chloride solution (1M) to pH = 1 and extracted with dichloromethane 
(3 x 30 ml). Combined dichloromethane fractions were dried over magnesium 
sulphate, filtered and concentrated in vacuum giving 657 mg (97%) of Boc-
TfmPro-OH as colourless crystals.  
 
Fmoc-TfmPro-OH. 
To a solution of Boc-TfmPro-OH (569 mg, 2.0 mmol) in 
dichloromethane (10 ml) trifluoroacetic acid (3 ml) was added, the solution was 
stirred at room temperature for 2 hours. Volatilities were removed under reduced 
pressure (temperature in bath 30° C), the residue was evaporated from 
dichloromethane (10 ml) once again. Water (10 ml), 10% sodium carbonate (7 
ml, to pH ~ 8-9) and acetone (5 ml) were subsequently added until clear solution 
was obtained, resulting mixture was cooled down in an ice bath. Suspension of 
Fmoc-OSu (745 mg, 2.2 mmol) in acetone (2 ml) was added within 1 min upon 
stirring, and then acetone (~ 10 ml) was added to the reaction mixture. 4 hours 
after adding the reagent the ice bath was removed and stirring was continued for 
25 hours at ambient temperature. Acetone was removed under reduced pressure 
(temperature in bath ≤ 31° C), the transparent solution was poured in water (100 
ml), and resulting suspension was extracted with diethyl ether (4 x 30 ml). The 
water layer was acidified by hydrogen chloride (1M) until pH ~ 1 and extracted 
by ethyl acetate (4 x 50 ml), the ethyl acetate fractions were dried over 
magnesium sulphate, filtered and evaporated, the residue was lyophilized from 









 HCl*H-trans-MePro-OH (99 mg, 0.61 mmol) was dissolved in water (3 
ml), 10% sodium carbonate (1.5 ml) was added until pH reached 8-9. Acetone 
(1.5 ml) was added, the mixture was cooled down in an ice bath and Fmoc-OSu 
(227 mg, 0.67 mmol) in acetine (2 ml) suspension was added over 0.5 min. 
Acetone (3 ml) and water (3 ml) were added in order to get clear solution and 
the mixture was stirred at ambient temperature 16h. Acetone was removed under 
reduced pressure and the residue was poured in water (50 ml). Water was 
extracted with diethyl ether (2 x 20 ml) and acidified with hydrogen chloride 
solution (1M, 3 ml) until pH ~ 1-2. The water was extracted with ethyl acetate (5 
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x 30 ml), the ethyl acetate fractions were dried over sodium sulphate, filtered 
and concentrated in vacuum. Lyophylization out of acetonitril-water mixture 








 H-Phg-OH (5 g, 33 mmol) was dissolved in 10% sodium carbonate 
solution (60 ml), acetone (25 ml) and additional water (30 ml) mixture. This 
mixture was cooled down in an ice bath. Fmoc-Cl (9.41 ml, 36.4 mmol) in 
acetone (35 ml) was added over 7 min upon stirring. The mixture was stirred for 
43h and was allowed to warm to room temperature. Acetone was removed under 
reduced pressure (temperature ≤ 30°C) and the residue was diluted with water 
(600 ml), extracted with diethyl ether (4 x 100 ml) and acidified by hydrogen 
chloride solution (1M, 70 ml) until acidic pH. The mixture was extracted with 
ethyl acetate (3 x 250 ml), the ethyl acetate fractions were dried over magnesium 
sulphate, filtered and evaporated. The product was lyophylized out of 
acetonitril-water.  10.26 g (83%) of Fmoc-Phg-OH was obtained as white 
powder. 
 
7.2. Peptide synthesis 
 
7.2.1. Synthesis of gramicidin S analogues 
 
 Was performed manually according to102 as described in chapters 3.4. The 
RP-HPLC purification was done on either semi-preparative or preparative 
columns. The synthesis type and analytical data for the peptides obtained is 
summarized in Table 7.1. HPLC was done as described above, only analytical 
biphenyl column of the same size was used instead of a C18, injected amount 
was 5 µl of 1 mg/ml solutions in acetonitrile-water. 19F-NMR of fluorine 
containing petides was done in acetonitril-water (1:1) solution. Analytical data 
for the peptides is summarized in Table 7.1. 
 
7.2.2. Synthesis of SAP analogues 
 
 Was performed manually according to44 as described in chapters 3.4. The 
RP-HPLC purification was done on either semi-preparative or preparative 
columns. The synthetic rout was denoted in Table 3.5. Analytical data for the 
peptides obtained is summarized in Table 7.2. HPLC was done as usual, 15 µl of 
1-3 mg/ml solutions in methanol were injected. 19F-NMR of fluorine containing 













calculated, Da MALDI-TOF, 
Th 
proline substituted 
I-flp-GS DPhe ivDde 1159.5 1160.3 15.35 m, -170.1 
II-flp-GS Val Boc 1177.5 1177.5 15.18 m, -170.1 
I-Flp-GS DPhe ivDde 1159.5 1161.2 15.25 m, -177.8 
II-Flp-GS DPhe ivDde 1177.5 1178.3 15.00 m, -177.8 
I-F2Pro-GS 
DPhe ivDde 1177.5 1178.3 15.63 dm, J= 235 Hz, -91.6; d, J= 234 Hz, -102.8 
II-F2Pro-GS 
DPhe Boc 1213.4 1214.6 15.79 dm, J= 234 Hz, -91.5; d, J= 236 Hz, -102.7 
I-c-MePro-GS DPhe Boc 1153.5 1154.0 15.74 - 
II-c-MePro-GS Val Boc 1165.5 1166.0 15.90 - 
I-TfmPro-GS DPhe Boc 1209.5 1211.2 15.86 d, J= 10Hz, -70.5 
II-TfmPro-GS Val Boc 1277.5 1278.3 16.16 d, J= 9Hz, -70.5 
I-A(c)-GS DPhe ivDde 1221.5 1222.6 15.94 m, -64.7 
II-A(c)-GS Val Boc 1301.5 1302.8 16.36 d, J= 7 Hz, -64.8 
I-B(t)-GS DPhe Boc 1221.5 1222.5 15.99 d, J= 7 Hz, -64.1 
II-B(t)-GS Val Boc 1301.5 1302.2 16.36 d, J= 7 Hz, -64.1 
I-t-F2MePro-GS 
DPhe Boc 1189.5 1191.5 15.78 dd, J= 158, 12 Hz, -127.8; d, J= 159 Hz, -152.7 
leucine substituted 
I-DFPhg-GS DPhe Boc 1179.5 1180.0 14.71 s, -106.8 
I-LPhg-GS 1180.1 15.36 s, -108.4 
II-D,DFPhg-GS  Boc 1217.4 1218.0 13.27 s, -112.5 
II-D,LFPhg-GS 1218.5 14.63 s, -112.1; s, -113.3 
II-L,LFPhg-GS 
(LGS) 
1217.5 15.12 s, -113.5 
II-D,DPhg-GS  Boc 1181.5 1182.0 13.06 - 
II-D,LPhg-GS 1182.0 14.54 - 
II-L,LPhg-GS 1182.3 15.27 - 
Table 7.1. Analytical data for the gramicidin S analogues. 
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SAP-TfmPro 2065.5 2066.1 9.08 d, J= 8 Hz, -69.7 
SAP-c-MePro 2009.5 2010.0 8.82 - 
SAP-t-MePro 2009.5 2009.4 8.60 - 
SAP-flp 2015.5 2016.0 8.59 m, -176.2 
SAP-Flp 2015.5 2016.1 8.58 m, -170.5 
SAP-B(t) 2077.5 2077.5 9.23 d, J= 7 Hz, -64.4 
SAP-t-F2MePro 2045.5 2045.6 8.87 dd, J= 162, 13 Hz, -129.2; 
d. J= 161 Hz, -152.9 
SAP-c-F2MePro 2045.5 2046.1 8.82 dd, J= 159, 12 Hz, -125.6; 
d, J= 159 Hz, -151.7 
Table 7.2. Analytical data for the SAP analogues. 
 
7.3. Antimicrobial activity test 
 
 Serial broth dilution test was done with all gramicidin S analogues 
according to the protocol107 modified as described
135. The peptides concentration after weighting was calibrated to the wild type 
GS concentration via HPLC and corrected by aliquotzing. 
 
7.4. Circular dichroism measurements 
 
 CD spectra of gramicidin S analogues were recordered on Jasco J-815 
Spectrophotometer. The measurements were done in a suprasil® 1 mm cell.The 
samples in trofluorethanol and deionized water were of 50 µM peptide 
concentration and were measured at 25°C. The phosphate buffer was of 20 mM 
concentration and pH 7.2 (at 30°C). The lipid vesicles were prepared according 
to the following protocol: the lipid (DLPC) was dissolved in methanol, and 
aliquotized by portions of 50 µl. For the samples with the reconstituted peptides 
the peptide 50 µl aliquote in methanol was added on this step. The methanol 
solution was dried by nitrogen current and then additionally dried under vacuum 
for at least 2 h.  300 µl portion of the PB was added such that the final peptide 
concentration was 37 mM and the lipid 0.92 mg/ml (resulting p/l was 1/40). The 
mixture was vortexed for 10 min, 8-10 times freeze-thaw cycles were performed 
by freezing in liquid nitrogen and warming in warm water. Resulting mixture 
was sonicated 4 x 4 min and the CD spectra were recordered at 30°C. For the 
mixed samples, the resulting suspension of the lipid vesicles was added to a dry 
peptide aliquote which was prepared accordingly. The mixture was vortexed for 
1 min before the measurements. 
 CD spectra of SAP analogues were done on CD12 beamline at 
synchrotron facility at the Karlsruhe Institute of Technology136. Measurements 
in solution were done in deionized water at 20°C. The peptides were aliquotized 
from the stock solutions in methanol and dried before being dissolved in water. 
Measurements at 10 mg/ml concentration were done in demountable 13 µm 
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CaF2 cell. Measurements at concentration 0.5 mg/ml were done in a suprasil® 
0.1 mm cell.   
 
7.5. Hemolysis assays 
 
 Human blood conserves were obtained in Städtisches Klinikum Karlsruhe. 
Two buffers were employed: “buffer 1” 160 mM Tris* with pH 7.6 at 4°C, 
“buffer 2” 160 mM Tris with pH 7.6 at 37°C. 
5 ml of the blood conserves was diluted with 45 ml of buffer 1, 
centrifuged 10 min at 231 g (1,500 rpm) and 4°C and the supernatant (~ 45 ml) 
was discarded. This operation was repeated twice. 1 ml of the residue was 
diluted with 9 ml of buffer 1 and the resulting suspension was then stored on ice 
as the stock suspension. Hemolytic tests of GS wild type which were done at the 
beginning at the end of the measurements (~ 5 h in between) showed fully 
consistent curves. 0.5 ml of the stock suspension was diluted with 9.5 ml of 
buffer 2 and 200 µl were aliquotized in each one vial with buffer 2 and peptides 
in different concentrations (200 µl of solution in each one) as well as with buffer 
2 only (negative control) and 0.2% solution of Triton X-100® (positive control). 
The mixtures of the blood cells and peptides in buffer 2 in corresponding vials 
were incubated 30 min at 37°C with gentle discrete shaking. Then the mixtures 
were centrifuged 10 min at 13,000 rpm, 320 µl of supernatant solution from each 
one vial was taken and absorption at 540 nm was measured at SmartSpec 
spectrophotometer. Buffer 2 was used as blank. Values from the negative 
control vial were controlled to be low and were taken in analysis as 0%, 
corresponding values from the positive control vials were taken as 100% 
hemolysis value. There were two rows of 2-fold dilution for each one peptide: 
1) 64-0.5 (8 values) and 50-1.6 (6 values) µg/ml for the medium hemolytic; 
2) 32-0.25 (8 values) and 25-0.4 (7 values) µg/ml for the high hemolytic; 
3) 150-2.3 (7 values) and 128-2 (7 values) µg/ml for the peptides with the 
homolysis lower as induced by the wild type GS. 
The peptides were originally dissolved in buffer 2:dimethylsulfoxide mixturee 
(9:1 vol) and then titrated in the vials with the buffer 2 such that the DMSO 
content was 5% in the vial with the 64 µg/ml startingconcentration. 
Few values with enormously high absorption (>> with Triton X-100®) 
were not taken in the analysis. These samples apparently contained blood cell 







                                                 
* tris(hydroxymethyl)aminomethane 
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Peptide hemolytic concentration, µg/ml 
HC25 HC50 HC75 
GS wild type 6.9 9.4 11.9 
I-Flp-GS 20.2 23.7 27.8 
II-Flp-GS 42.0 58.7 71.2 
I-flp-GS 13.3 17.2 22.5 
II-flp-GS 10.3 15.3 20.6 
I-F2Pro-GS 3.4 4.5 5.7 
II-F2Pro-GS 1.2 2.0 2.7 
I-c-MePro-GS 4.1 6.1 7.4 
II-c-MePro-GS 3.5 4.8 6.3 
I-t-F2MePro-GS 4.0 5.0 6.4 
I-TfmPro-GS 1.6 2.2 2.8 
II-TfmPro-GS 0.6 1.1 2.0 
I-A(c)-GS 3.4 4.7 6.1 
II-A(c)-GS 1.1 1.9 2.6 
I-B(t)-GS 1.4 2.8 4.1 
II-B(t)-GS 0.5 0.7 1.2 
Table 7.3. Hemolytic concentrations of proline substituted gramicidin S analogues. 
 
7.6. Solid state NMR studies in lipid bilayers 
 
7.6.1. Instruments and pulses 
 
19F- and 31P-NMR spectra of peptide in lipid samples were recordered at: 
- Bruker Avance 500 NMR system with a wide bore magnet equipped with: 
1) for 19F spectra (470.6 MHz) 1H19F double resonance variable angle flat coil 
probe (Doty Scientific), 90 deg pulse of 2.1 µs and 126 W, decoupling 8 W; 2) 
for 31P spectra (202.5 MHz) 1H/19FX variable angle flat coil probe (Bruker), 90 
deg pulse 7.1 µs and 125 W, decoupling 13 W. 
- Bruker Avance 500 III NMR system with a wide bore magnet equipped with: 
1) for 19F spectra (470.6 MHz) 1H19F lowE137 coil probe (home built), 90 deg 
pulse of 3.4 µs and 75 W, decoupling 16 W; 2) for 31P spectra (202.5 MHz) 
1HXY lowE flat coil probe (home built), 90 deg pulse of 5µs and 48 W, 
decoupling 16 W. 
- Bruker Avance 300 NMR system with wide bore magnet equipped with: 
1) for 19F spectra (282.4 MHz) 1H19F lowE coil probe (home-built), 90 deg pulse 
of 3.0 µs and 158 W, decoupling  8 W. 
The proton decoupling power corresponded to the 15-20kHz actual 
decoupling strength. 
For 31P-NMR spectra hahnecho pulse sequence with decoupling was 
applied (30 µs echo delay, 10-20 ms acquisition time and 2 s recycling delay). 
For 19F spectra: 1) for mono fluorine system hahnecho sequence with decoupling 
(30 µs echo delay, 20 ms acquisition time and 2 s recycling delay); 2) for 
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geminal difluoro substituted peptides single pulse sequence with decoupling was 
applied (2 µs acquisition time, and 3 s recycling delay); 3) for trifluoromethyl 
substituted peptides composite aring sequence with decoupling was applied (2 
µs acquisition time, and 1 s recycling delay). 
 
7.6.2. Peptide-lipid samples preparation 
 
Typical procedure for a sample with p/l = 1/40. 
Peptide (0.5-0.7 mg) was co-dissolved with the lipid (10-14 mg) in either 
methanol or methanol-chloroform (2:1) mixture and spread over 12-17 glass 
plates (Marienfeld Laboratory Glassware) such that the amount per a glass plate 
was 0.7-0.8 mg for 18 x 7.5 mm and 0.6-0.7 mg for 15 x 7.5 mm glass plates 
(30-50 µl per a glass plate). The solvent was allowed to dry out for 30-60 min 
and the glass plates were dried in vacuum for at least 4 hours. They were then 
stacked and hydrated in chambers with saturated potassium sulphate (96% 
relative humidity) for 12-24 hours and finally wrapped in Nescofilm® and 
Sarogold® films. The samples were stored at -20°C between the measurements. 
 
7.6.3. Miscellaneous experimental parameters 
 
 The samples were thermostated by gas flow 1200, 1600 or 2000 l/h 
depending on the temperature range. The pre-acquisition delay used for the 
proper thermostating was 5-10 min (also within temperature series). 
Processing was done in Topspin 2.1. Exponential window function (em) 
was taken with different Lorenzian broadening (lb) parameters, typically 100-
300 Hz for the liquid-crystalline and ~500 Hz for the gel lipid states. Within 
temperature series lb was always taken the same. 
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